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1.1 Summary 
 
For almost two decades the dogma of the unifying hypothesis published by Brownlee defines 
the major research topics in the field of diabetes research. Unfortunately, normalization of 
blood glucose levels using insulin treatment can postpone or reduce but cannot prevent 
diabetic late complications. Factors related to obesity may play an important role and are 
pivotal for the severity and progression of type 2 diabetes. Therefore, this thesis focuses at 
three characteristics observed during the progression of diabetic nephropathy, i.e. leptin 
signaling, iron overload and reduction of GPx-4 protein abundance leading to ferroptosis of 
podocytes. We assume that even though obesity leads to impaired leptin signaling in 
neurons of the central nervous system, high leptin signaling takes place in peripheral organs 
like the kidney, contributing to obesity-related disorders. 
The aim of this study was to show that hyperglycemia itself is not the main reason for 
developing diabetic nephropathy, but rather an epiphenomenon pivotal to induce a self-
reinforcing feedback loop driving the inactivation of GPx-4. The resulting detrimental 
accumulation of lipid hydroperoxides could trigger the novel programmed cell death pathway 
ferroptosis in podocytes, which might explain the loss of these cells during the progression of 
the disease. 
In the present study we demonstrate that microvascular endothelial cells respond to leptin 
with an increased release/activation of transforming growth factor (TGF) β1 çausing 
downregulation of GPx-4 protein in the nearby podocytes. Moreover, a role of leptin signaling 
and systemic iron overload was analyzed ex vivo by quantifying the amount of GPx-4 protein 
and iron in the glomeruli of db/db mice, db/db/Fpn+/- mice and leptin-deficient ob/ob mice. 
GPx-4 protein abundance was slightly reduced in the glomeruli of 32-42 weeks old db/db 
mice. This decline of GPx-4 protein abundance was augmented in db/db/Fpn+/- mice of the 
same age. In contrast, the amount of iron was significantly increased in the glomeruli of 
these mice. Impaired iron homeostasis could influence the activity of GPx-4 in podocytes as 
we showed that iron accumulates in the glomeruli of Fpn+/- mice. The co-action of both the 
downregulation of GPx-4 in podocytes induced by leptin signaling in glomerular endothelial 
cells in combination with the postulated accumulation of iron in the podocytes could thus 
trigger a negative and self-sustained feedback loop. 
Obesity is a major risk factor for the development of type 2 diabetes but so far, its 
relationship with diabetic kidney disease remained unclear. This thesis may have helped to 
gain insight into one important aspect of the pathogenesis of obesity-related diabetic 
nephropathy and to facilitate the development of fu
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1.2. Zusammenfassung 
 
Die Diabetesforschung wird seit mehr als zwei Jahrzehnten von der Brownlee-Hypothese der 
hyperglykämiebedingten Gefäßschädigung dominiert. Leider können durch die 
Normalisierung der Blutzuckerwerte diabetische Spätschäden nur aufgeschoben, aber nicht 
verhindert werden. Diese Tatsache führt zur Annahme, dass andere Faktoren, die in 
Verbindung mit Übergewicht stehen, eine übergeordnete Rolle bei der Entstehung von T2D 
spielen. Die vorliegende Studie legt daher einen Schwerpunkt auf drei charakteristische 
Eigenschaften, die mit dem Fortschreiten einer diabetischen Nephropathie einhergehen: 
Leptin-Signaltransduktion, eine systemische Eisenüberladung, Reduzierung der GPx-4 
Proteinmenge in den Podozyten, sowie die daraus resultierende als Ferroptose bekannte 
Form des Zelltods. Krankhaft übergewichtige Menschen weisen meist eine Leptinresistenz 
und Störung im Leptin-Signalweg in Neuronen des zentralen Nervensystems auf. Dennoch 
wird in peripheren Organen wie der Niere eine gesteigerte Leptin-Signalwirkung 
angenommen, die die Entstehung von Folgeerkrankungen begünstigen. 
Das Ziel dieser Studie war es zu zeigen, dass Hyperglykämie eher eine Begleiterscheinung 
und nicht den Hauptgrund für die Entwicklung einer diabetischen Nephropathie darstellt. 
Trotzdem ist die Hyperglykämie essenziell für die Einleitung der positiven Rückkopplung, die 
zu einer Inaktivierung der GPx-4 führt. Eine zellschädigende Akkumulation von 
Lipidperoxiden löst möglicherweise die programmierte Zelltodform Ferroptose in Podozyten 
aus und könnte den Verlust dieser Zellen während des Verlaufs einer diabetischen 
Nephropathie erklären.  
In der vorliegenden Studie konnte gezeigt werden, dass mikrovaskuläre Endothelzellen nach 
Leptin-Stimulation TGF-β1 freisetzen, was in kokultivierten Podozyten zu einer Reduktion der 
GPx-4 Proteinmenge führte. Zusätzlich wurde die GPx-4 Proteinmenge und die Eisenmenge 
in den Glomeruli von db/db Mäusen, Fpn+/- Mäusen, db/db/Fpn+/- Mäusen und Leptin-
defizienten ob/ob Mäusen quantifiziert. Im Vergleich zu den Wildtypkontrolltieren war die 
Reduktion der GPx-4 Proteinmenge in den Glomeruli von 32-42 Wochen alten db/db/Fpn+/- 
Mäusen deutlich stärker ausgeprägt, als in den db/db Mäusen, bei denen die GPx-4 
Proteinmenge nur leicht reduziert war. In den Glomeruli der Fpn+/- Mäuse konnte 
andererseits eine deutlich höhere Menge an Eisen im Vergleich zu den Kontrolltieren 
festgestellt werden. Die durch die beeinträchtigte Eisenhomöostase verursachte 
Eisenüberladung in den Glomeruli der Fpn+/- Mäuse könnte die Aktivität der GPx-4 in den 
Podozyten negativ beeinflussen. Das Zusammenspiel von einer Leptin-induzierten 
Reduzierung der GPx-4 Proteinmenge in den glomerulären Endothelzellen und der 
postulierten Eisenüberladung in den Podozyten könnte eine positive Rückkopplung 
11 
 
auslösen, die zu einer massiven Akkumulation von Lipidperoxiden führt, da diese 
hauptsächlich von der GPx-4 reduziert werden.  
Obwohl Übergewicht als einer der Hauptfaktoren gilt, die zu einer Entwicklung von Typ 2 
Diabetes beitragen, ist der kausale Zusammenhang vor allem bei der Entstehung der 
diabetischen Nephropathie bislang unzureichend geklärt. Mein Projekt liefert erste Daten 
über mechanistische Zusammenhänge von Adipositas und der Pathogenese einer Leptin-
abhängigen diabetischen Nephropathie und trägt somit möglicherweise zu der Entwicklung 
von Therapiemöglichkeiten bei. 
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2. Introduction 
 
2.1 Diabetes mellitus 
 
Diabetes mellitus is a chronic metabolic disorder affecting 8.3 % of the population worldwide 
causing microvascular complications, such as neuropathy, retinopathy or nephropathy. In 
2015 415 million people worldwide suffered from diabetes and its complications (Mbanya, 
Sandow et al. 2017). By 2040 this figure will rise to over 642 million. Among those, 5 million 
people are dying each year (Mbanya, Sandow et al. 2017). In Germany every tenth adult 
suffers from diabetic complications (Koster, Huppertz et al. 2011). According to the 
International Diabetes Federation numbers have doubled over the last 20 years. Moreover, 
diabetic late complications are the major risk factor for developing macrovascular disease 
such as heart attack and stroke, which are responsible for the high mortality rate among 
these patients (Wolf 2004, Mbanya, Sandow et al. 2017). Diabetes is characterized by high 
levels of blood glucose and the inability of the body to take it up into the cells (de Mello, 
Orellana et al. 2019). According to the WHO, diabetes is defined as fasting blood glucose 
levels above 126 mg/dL (7 mM/L) (Alberti and Zimmet 1998). Glucose concentrations in the 
blood can be easily quantified, either by measuring glucose itself or by analyzing 
glycosylated hemoglobin (HbA1c). Blood glucose concentrations give only information about 
the current glucose level, whereas HbA1c represents the average glucose level over the last 
12 weeks. After glucose changes its conformation via Amadori rearrangement, it can be non-
enzymatically attached to hemoglobin. Moreover, HbA1c in the blood is degraded after 3 
months. Thus, the proportion of HbA1c can be used as a reliable readout of the mean 
glucose level over the last 12 months. Under physiological conditions about 5 % of the total 
amount of glucose is glycosylated. In people suffering from diabetes more than 6.5 % of the 
total amount of glucose is glycosylated (HbA1c > 6.5 %) (Alberti and Zimmet 1998). Blood 
glucose concentrations rise after food intake. In response to high glucose levels β-cells in the 
pancreas produce the hormone insulin, which is responsible for immediate glucose uptake 
into the skeletal muscles via activation of insulin-dependent glucose-transporter 4. Glucose 
can either be consumed or stored as glycogen. Low levels of insulin or insulin resistance are 
responsible for high blood glucose concentrations (Dupont and Scaramuzzi 2016). Thus, it 
can be discriminated between people suffering from a low insulin production (type 1 
diabetes) and people suffering from insulin resistance (type 2 diabetes) (Alberti and Zimmet 
1998). 
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2.1.1 Type 1 diabetes (T1D) 
 
Ten percent of people suffering from diabetes can be grouped into T1D (Alberti and Zimmet 
1998). More than 40 genes could be identified as risk genes to develop T1D. The outbreak of 
the disease occurs usually early at adolescence (Saberzadeh-Ardestani, Karamzadeh et al. 
2018). Patients with the autoimmune disease T1D lose pancreatic β-cells during the 
progression of the disease (Coward, Welsh et al. 2005). Initially, the remaining β-cells can 
compensate for this loss by increasing the insulin production per cell. As soon as the critical 
mass of β-cells reaches a certain threshold, the remaining β-cells can not compensate for the 
loss anymore, which causes the outbreak of the disease (Saberzadeh-Ardestani, 
Karamzadeh et al. 2018). As a consequence, glucose uptake into skeletal muscles is no 
longer sufficient. Thus, the glucose supply can meet the needs, but can no longer sufficiently 
reach the cells. The surplus glucose contributes to high blood glucose levels. 
 
2.1.2 Type 2 diabetes (T2D) 
 
With 90 % the majority of people suffering from diabetes can be grouped into T2D (Alberti 
and Zimmet 1998). T2D is not characterized by a loss of β-cells, but rather by insulin 
resistance (Coward, Welsh et al. 2005). In this case, the β-cells need to produce more insulin 
to reach the same level of action. This occurs when the β-cells are not capable to further 
increase insulin production (Dupont and Scaramuzzi 2016). As a consequence, glucose 
uptake into skeletal muscles is no longer sufficient. The remaining glucose increases the 
blood glucose levels. Moreover, low levels of insulin increase gluconeogenesis in the liver. 
Thus, blood glucose levels are further increased. A genetic predisposition as well as 
environmental factors, e.g. lifestyle, are responsible for the development and progression of 
the disease (Risérus, Willett et al. 2009). Lifestyle interventions such as reduction of visceral 
body fat as well as increased physical activity can reduce the severity of T2D (Sjostrom, 
Lindroos et al. 2004, Maggard, Shugarman et al. 2005, Dintsios, Chernyak et al. 2018).  
 
2.2 Obesity 
 
There is a strong correlation between T2D and obesity. Moreover, it is thought that obesity 
initiates the transition from a physiological to a pathophysiological state. Obese people have 
a high risk to develop cardiovascular diseases and T2D, and frequently suffer from metabolic 
syndrome (Wolf 2004), which is characterized by high blood pressure, hyperglycemia, high 
14 
 
serum triglycerides, low serum levels of high-density lipoprotein, insulin and leptin resistance 
(Risérus, Willett et al. 2009). In addition, obesity provokes a pro-inflammatory environment in 
people with T2D (Wolf, Chen et al. 2002). Apart from the genetic background excessive food 
intake, lack of physical activity, sleep deprivation, drinking and smoking are risk factors for 
developing an obese phenotype (Riserus, Willett et al. 2009). A subsequent 10 % reduction 
of visceral fat by lifestyle interactions or surgeries inter alia gastric bypass can reverse some 
of the detrimental effects of the metabolic syndrome and thus some of the detrimental effects 
of T2D (Sjostrom, Lindroos et al. 2004, Maggard, Shugarman et al. 2005, Disse, Pasquer et 
al. 2014).  
 
2.3 Leptin signaling  
 
Leptin is a 16 kDa protein expressed in white adipose tissue (Wolf, Chen et al. 2002). 
Therefore, the level of the hormone leptin correlates with the amount of white adipose tissue 
(Han, Isono et al. 2001, Goto, Kaneko et al. 2016). Moreover, T2D is associated with obesity 
(Honda, Ikejima et al. 2002, Dam, Jockers et al. 2015). This suggests that there might be a 
causal link between obesity and T2D. Six splice variants of the leptin receptor (Ob-Rb, Ob-
Ra, Ob-Rc, Ob-Rd, Ob-Re and Ob-Re, cf. Figure 1) are known so far (Wolf, Chen et al. 
2002, Goto, Kaneko et al. 2016). The extracellular leptin binding domains (C-terminus) of the 
different leptin receptor splice variants are identical, whereas the intracellular leptin binding 
domains (N-terminus) differ in their length (Friedman and Halaas 1998, Adya, Tan et al. 
2015). In healthy individuals, leptin reaches the hypothalamus (Han, Isono et al. 2001) in the 
brain via the blood-brain-barrier causing an inhibition of neuropeptide Y and agouti-related 
peptide and stimulation of pro-opiomelanocortin in two subpopulations of neurons (Fei, 
Okano et al. 1997, Friedman and Halaas 1998). Leptin induces a feedback loop via binding 
to the long leptin receptor splice variant Ob-Rb causing reduction of food intake and increase 
of energy expenditure (Fei, Okano et al. 1997, Friedman and Halaas 1998, Han, Isono et al. 
2001). Ob-Rb contains a Janus kinase (JAK)/signal transducer and activator of transcription 
3 (STAT3) binding motif in the intracellular domain (Wolf, Chen et al. 2002, Li, Ceccarini et 
al. 2013). Thus, leptin binding to Ob-Rb induces activation of JAK (Figure 2). Furthermore, 
activated JAK phosphorylates tyrosine residues of Ob-Rb, leading to phosphorylation of 
STAT3 (Dam, Jockers et al. 2015). In turn, phosphorylated STAT3 homodimers translocate 
to the nucleus and activate gene transcription (Fei, Okano et al. 1997, Li, Ceccarini et al. 
2013) (Figure 2). This signaling cascade and the resulting feedback loop seems to be 
impaired in obese patients (Han, Isono et al. 2001, Dam, Jockers et al. 2015, Goto, Kaneko 
et al. 2016).  
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In peripheral organs, e.g. the kidneys, the short splicing variants of the leptin receptor Ob-Ra 
and Ob-Rc are highly abundant (Hoggard, Mercer et al. 1997, Han, Isono et al. 2001, De 
Matteis, Dashtipour et al. 2007, Li, Ceccarini et al. 2013, Goto, Kaneko et al. 2016). Even 
though it was long time believed that only the long leptin splice variant Ob-Rb is able to 
signal via the JAK/STAT signaling pathway, it is more and more accepted that the short 
splicing variants also play a major role in leptin signaling (De Matteis, Dashtipour et al. 2007, 
Li, Ceccarini et al. 2013, Goto, Kaneko et al. 2016). The development of leptin resistance 
remains unclear (Friedman and Halaas 1998, Honda, Ikejima et al. 2002, Dam, Jockers et al. 
2015). It is likely that transport via the blood brain barrier is somehow impaired (Friedman 
and Halaas 1998). In this case, only signaling in the brain, e.g. the described feedback loop, 
is impaired (Dam, Jockers et al. 2015). Leptin signaling may still be intact in peripheral 
tissues such as the kidneys and should be increased in a pathophysiological state (De 
Matteis, Dashtipour et al. 2007, Goto, Kaneko et al. 2016).  
    
 
2.4 Hyperglycemia 
 
In both T1D and T2D, insulin substitution is the treatment of choice. Even if glucose levels in 
patients suffering from diabetes are tightly controlled, they develop diabetic late 
complications (Martín-Gallán, Carrascosa et al. 2003, Falkevall, Mehlem et al. 2017, Cooper, 
El-Osta et al. 2018). These complications are postponed but cannot be prevented (UK 
Prospective Diabetes Study Group 1998, Martín-Gallán, Carrascosa et al. 2003, Falkevall, 
Mehlem et al. 2017). According to the unifying hypothesis of Brownlee, increased ROS 
Figure 1: Isoforms of the leptin receptor 
derived from differential splicing. From Wolf, 
G. American Journal of Kidney Diseases 
(2002), 39:1-11 
Figure 2: Overview of leptin signaling 
through the Ob-Rb isoform. From Wolf, G.
American Journal of Kidney Diseases (2002), 
39:1-11. STAT (transcription factor Signal 
Transducer and Activator of Transcription), 
JAK (Janus kinase)  
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formation during hyperglycemia inhibits the catalytic enzyme GAPDH, therefore preventing 
the metabolism of glyceraldehyde-3-phosphate into 1,3 diphosphoglycerate (Brownlee 2001). 
Thus, alternative metabolic pathways such as the polyol pathway (Giacco and Brownlee 
2010), the hexosamine pathway (Brownlee 2005), the protein kinase C pathway (Thallas-
Bonke, Thorpe et al. 2008) and the AGE pathway (Makita, Radoff et al. 1991, Nigro, Leone 
et al. 2017) should be activated. According to Brownlee late diabetic complications can be 
easily prevented by tight glucose control (Brownlee 2001, Cooper, El-Osta et al. 2018). 
Nevertheless, patients with diabetes develop late complications even if their glucose levels 
are tightly controlled (Martín-Gallán, Carrascosa et al. 2003, Falkevall, Mehlem et al. 2017, 
Cooper, El-Osta et al. 2018). Maybe diabetes is not a disease but rather a phenotype defined 
by the biomarker glucose.  
 
2.5 Physiology and pathophysiology of the kidney 
 
2.5.1 The function of the kidney 
 
The kidney is the organ responsible for maintaining and regulating water and electrolyte 
homeostasis. In addition, the two bean-shaped kidneys take part in acid-base homeostasis 
as well as detoxification processes. The human kidney consists of 1 to 2.5 million glomeruli, 
in which the ultrafiltration of the blood occurs (Scott and Quaggin 2015). In healthy 
individuals, large proteins like albumin cannot pass the filtration barrier, which is size and 
charge selective (Haraldsson, Nystrom et al. 2008). The filtration barrier consists of a 
monolayer of fenestrated endothelial cells at the luminal side (Ballermann 2007, Hale and 
Coward 2013), a three-layer basal membrane and a monolayer of podocytes covering the 
other side of the capillaries in the Bowman´s capsule (Figure 3) (Lewko, Bryl et al. 2005). 
Both cells types are in close proximity only separated by the glomerular basal membrane.  
Glomerular endothelial cells (gECs) are microvascular endothelial cells characterized by 
fenestrations of 60 to 100 nm trans-cellular pores essential for high water permeability 
(Ballermann 2007, Hale and Coward 2013). They represent the first part of the filtration 
barrier, withdrawing large proteins such as albumin from the urine. The glomerular 
endothelial cell surface is covered by a thick glycocalyx, which is responsible for some of the 
characteristic properties of these cells. The glycocalyx is a negatively charged 200 nm thick 
layer consisting of proteoglycans and glycoproteins covalently bound to the endothelial cell 
membrane (Haraldsson and Nystrom 2012). The glomerular basal membrane is mainly built 
up by type IV collagen, laminin and negatively charged proteoglycans (Deen, Lazzara et al. 
2001).  
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Figure 3: Schematic drawing of a glomerulus. Graph was provided by wbanimalhospital.com 
Podocytes represent the last part of the filtration barrier (Figure 3). These epithelial cells are 
located at the other side of the glomerular basal membrane (GBM) facing towards the 
Bowman´s capsule (Pavenstadt, Kriz et al. 2003, Krtil, Platenik et al. 2007, Ni, Saleem et al. 
2012). They consist of a cell body and many foot processes, which connect them to the 
glomerular basal membrane (Deen, Lazzara et al. 2001, Pavenstadt, Kriz et al. 2003). The 
foot processes multiply the surface of the tight notched podocytes (Ni, Saleem et al. 2012). 
Small gaps between the podocyte foot processes are covered by the slit diaphragm (Krtil, 
Platenik et al. 2007). These slits are 3-5 nm wide and represent a sieve that the ultra-filtrate 
has to pass (Furukawa, Ohno et al. 1991). Podocytes are post-mitotic cells with a tightly 
controlled cell cycle (Vallon and Komers 2011, Ni, Saleem et al. 2012). As soon as the 
podocyte precursor cells differentiate to podocytes, the cell cycle arrests completely, 
because they express high amounts of the cell cycle inhibitors p27 and p57, which are 
responsible for the inhibition of cell cycle maintaining cyclin-dependent kinases (Barisoni, 
Mokrzycki et al. 2000, Pavenstadt, Kriz et al. 2003, Vallon and Komers 2011). At the same 
time, these cells express markers specific for differentiated podocytes such as podocin, 
nephrin and synaptopodin (Pavenstadt, Kriz et al. 2003). Once the podocyte monolayer is 
disrupted through a loss of podocytes, the number of podocytes constantly decreases. 
Instead of reentering the cell cycle for cell proliferation the remaining podocytes increase 
their size (hypertrophy) (Pavenstadt, Kriz et al. 2003, Vallon and Komers 2011). Thus, cell 
hypertrophy is the only mechanism by which podocytes can cope with increased functional 
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demands, whereas other glomerular cells can adapt by cell proliferation (Barisoni, Mokrzycki 
et al. 2000).  
Besides endothelial cells and podocytes a glomerulus consists of parietal epithelial cells 
forming the Bowman´s capsule as well as mesangial cells (Figure 3). Mesangial cells control 
the intraglomerular capillary blood flow and contribute to the composition of the extracellular 
matrix (Vallon and Komers 2011). Both, mesangial cells and extracellular matrix form the 
mesangium, a scaffold for the glomerular capillaries (Deen, Lazzara et al. 2001, Pavenstadt, 
Kriz et al. 2003).  
 
2.5.2 Diabetic nephropathy 
 
Diabetic nephropathy is the main reason for end-stage renal disease (ESRD) (Susztak, Raff 
et al. 2006), characterized by albuminuria (Sharma, McCue et al. 2003), reduced filtration, 
expansion of the mesangium (Wolf 2004), basal membrane thickening and podocyte loss 
(Vallon and Komers 2011, Reidy, Kang et al. 2014). Thirty percent of patients with T1D and 
30 % of patients with T2D develop diabetic nephropathy (Ritz 2006). As soon as patients 
have been diagnosed suffering from kidney failure and to be in need of future dialysis the 
chance to survive is as low as with the most severe types of cancer. The reason why some 
of the people suffering from diabetes develop diabetic nephropathy and some do not is not 
well understood (Ritz 2006). At the beginning of diabetic nephropathy, the glomerular 
filtration rate (GFR) increases from about 100 mL/min to over 150 mL/min (Forbes and 
Cooper 2013), (Rossing 2015) (Figure 4). This hyperfiltration occurs only in the pre-diabetic 
phase lasting for about 5 years after the onset of diabetes. The GFR consolidates at 100  
 
Figure 4: The phases of diabetic nephropathy. From Rossing, P. Clinical pathology of nephropathy 
[internet]. 2015 Sep 23; Diapedia. GFR (Glomerular Filtration Rate) 
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mL/min five to fifteen years after the onset of diabetes (Najafian, Alpers et al. 2011). This 
phase is termed incipient diabetic nephropathy. 15 years after the onset of diabetes the 
decline of kidney function drops dramatically from around 100 mL/min to less than 50 mL/min 
(Rossing 2015).  
Frequently, kidney damage is diagnosed at the beginning of this phase termed overt diabetic 
nephropathy. Unfortunately, at this stage the damage is irreversible because the disease 
lasts already for 15 years (Breyer, Bottinger et al. 2005) (Figure 4). Drug treatment can 
postpone the next phase to some extent into the future but cannot prevent end-stage renal 
disease where GFR drops to near zero resulting in total organ failure (Rossing 2015).  
Albumin is a large serum protein, which is withdrawn by an intact filtration barrier (Vallon and 
Komers 2011). Thus, in addition to GFR, the amount of albumin in the urine is an indicator 
for the integrity of the filtration barrier (Najafian, Alpers et al. 2011). Under physiological 
conditions (normoalbuminuria) urinary albumin secretion is less than 30 mg per day (Figure 
4). Microalbuminuria is defined between 30 mg and 300 mg albumin secreted per day, which 
successively increases during the first 15 years of the disease (Rossing 2015). Moreover, the 
kidney is irreversibly damaged if the albumin secretion rate exceeds 300 mg per day, which 
is defined as macroalbuminuria (Rossing 2015). The reason to develop diabetic nephropathy 
is multifactorial. Therefore, the progression of the disease and the duration at each phase 
differs between individuals and cannot be traced back to a single event (Freedman, Bostrom 
et al. 2007). Kidney biopsies from patients with T2D show a significant reduction of the 
number of podocytes (Pagtalunan, Miller et al. 1997, Schiffer, Bitzer et al. 2001, Susztak, 
Raff et al. 2006, Vallon and Komers 2011). It is not known whether podocytes loss occurs 
early at the stage of microalbuminuria (Susztak, Raff et al. 2006) or late at the stage of 
macroalbuminuria or even end-stage renal disease.  
 
2.6 TGF-β1 signaling 
 
2.6.1 TGF-β1 processing 
 
TGF-β1 is the most important member of the TGF-β superfamily, as it has the highest affinity 
to TGF-β type I and II receptors, even though TGF-β2 and TGF-β3 can bind to the same 
receptor. It is synthesized as a precursor protein with a pro-peptide region (Travis and 
Sheppard 2014). After synthesis, TGF-β homodimers interact with the Latency Associated 
Peptide (LAP) and form the Small Latent Complex (Figure 5). In addition, the Small Latent 
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Complex interacts with the Latent TGF-β Binding Protein (LTBP) and forms the Large Latent 
Complex (Travis and Sheppard 2014). Moreover, the Large Latent Complex is 
 
Figure 5: TGF-β activation and function in immunity. From Travis, M. A. Annual review of 
immunology (2014), 32:51-82. LAP (Latency Associated Peptide), LTBP (Latent TGF-β Binding 
Protein) 
released to the extracellular matrix, where it is bound until it is further released. TGF-β 
remains inactive as long as it is bound to the complex (Travis and Sheppard 2014). Either 
the whole complex can be released from the extracellular matrix and remains inactive until it 
is further cleaved or the disulfide bonds connecting the active TGF-β to the complex can be 
cleaved directly at the extracellular matrix (Travis and Sheppard 2014). The latter leads to a 
release of active TGF-β directly from the extracellular matrix. Activation of TGF-β1 requires 
the separation of its active form from the complex by proteases or metalloproteases, ROS, 
thrombospondin-1, alpha 4 containing integrins or even by changes in pH (Travis and 
Sheppard 2014).  
 
2.6.2 Paracrine TGF-β1 signalling  
 
It was recently published that glomerular endothelial cells release growth factors after leptin 
binding (Wolf, Chen et al. 2002, Vallon and Komers 2011, Goto, Kaneko et al. 2016) (Figure 
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6). Growth factors such as TGF-β1 affect mesangial cells through paracrine signaling (Wolf, 
Chen et al. 2002). This was postulated because TGF-β type II receptors are upregulated in 
mesangial cells after leptin treatment in vitro. Thus, endothelial cell-derived TGF-β1 binds to 
mesangial TGF-β type II receptors and recruits TGF-β type I receptors followed by an 
activation of the SMAD (Small Mothers of Decapentaplegic) pathway (Wolf, Chen et al. 
2002), (Kanwar, Sun et al. 2011). This paracrine signaling between endothelial and 
mesangial cells can be applied to endothelial cells and podocytes, as they are localized in 
close proximity to the endothelial cells in the glomeruli (Figure 6) (Wolf, Chen et al. 2002).   
 
 
 
 
 
 
 
2.7 Redox signaling 
 
2.7.1 Reactive oxygen species 
 
Oxidative stress can be described as an imbalance between the production of ROS and their 
detoxification (Cai and Yan 2013). It is still debated whether enhanced ROS formation (Tang, 
Luo et al. 2014) or impaired ROS detoxification is responsible for higher ROS levels in T2D 
(Tavafi 2013, Cooper, El-Osta et al. 2018). Highly reactive ROS such as hydrogen peroxide 
can reversibly or irreversibly modify cell membranes or proteins via oxidation processes 
(Moller, Rogowska-Wrzesinska et al. 2011, Ray, Huang et al. 2012). Reversible protein 
modifications are cysteine-modifications including intramolecular or intermolecular disulfide 
bond formations (Cai and Yan 2013). Thus, protein function as well as protein stability are 
changed by such modifications (Brieger, Schiavone et al. 2012). Among all oxidative protein 
modifications carbonylation is the most common (Cattaruzza and Hecker 2008, Moller, 
Rogowska-Wrzesinska et al. 2011). Hydrogen peroxide can react with free iron and form 
hydroxy radicals, which can selectively introduce carbonyl groups into proteins (Cai and Yan 
Figure 6: Paracrine TGF-β1 pathways between glomerular endothelial and podocytes 
mediated by leptin. Schematic drawing modified from Wolf, G. American Journal of Kidney 
Diseases (2002), 39:1-11. TGF-β1 (Transforming growth factor β1) 
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2013). There are two possible ways by which such carbonyl derivatives can emerge. Amino 
acids can be oxidized directly through an oxidative attack of hydroxy radicals to lysine, 
arginine, proline or threonine residues at the amino acid side chains or indirectly through 
secondary reactions of the amino acids lysine, cysteine or histidine (Moller, Rogowska-
Wrzesinska et al. 2011). In this case, reactions occur with carbohydrates or AGEs which 
have been oxidized beforehand (Kalapos 2008).  
 
2.7.2 Glutathione peroxidases (GPx) 
 
Glutathione peroxidases (GPx) are antioxidant defense enzymes expressed in all kinds of 
tissues that reduce peroxides (Takebe, Yarimizu et al. 2002). They are selenoenzymes, as 
they contain selenium in their active center (Lubos, Loscalzo et al. 2011, Conrad and 
Friedmann Angeli 2015). This is a unique feature occurring only in 24 other human proteins 
(Fang, Goldberg et al. 2010). GPxs are the main detoxifying redox enzymes in the 
mammalian body which use glutathione as a co-factor (Lubos, Loscalzo et al. 2011). Thus, 
reduced glutathione is oxidized by enzymes of the GPx family. Moreover, oxidized 
glutathione is reduced by glutathione reductase utilizing electrons from nicotinamide adenine 
dinucleotide phosphate (NADPH) back to its reduced state (Takebe, Yarimizu et al. 2002). 
The ratio of reduced to oxidized glutathione is important for several enzymes such as, e.g. 
carnosinase 1, which cleaves carnosine (Peters, Schmitt et al. 2017). Three out of eight 
known isoforms (Brigelius-Flohe and Maiorino 2013) of glutathione peroxidases, GPx-1, 
GPx-3 and GPx-4 are found in the kidney (Burk, Olson et al. 2011, Wiedenmann, Dietrich et 
al. 2018).  
GPx-1 is expressed ubiquitously in all kinds of tissue and forms homotetramers (Lubos, 
Loscalzo et al. 2011). Its tertiary structure prevents big proteins from reaching the catalytic 
center. Therefore, its main function is to reduce small peroxides such as the highly reactive 
hydrogen peroxide or peroxinitrite in the cytoplasm (Wagner, Kautz et al. 2009, Lubos, 
Loscalzo et al. 2011, Cozza, Rossetto et al. 2017).  In contrast, GPx-4 forms active 
monomers that are able to detoxify large molecules as there is no steric interference with 
other subunits. The main substrates of GPx-4 are lipid hydroperoxides (Doll and Conrad 
2017, Shah, Shchepinov et al. 2018) such as phospholipid and cholesterin hydroperoxides, 
but it can also detoxify hydrogen peroxide (Conrad and Friedmann Angeli 2015). GPx-4 is 
found mainly at cell membranes, but also in the cytoplasm or in the nucleus (Gao, Monian et 
al. 2016, Cozza, Rossetto et al. 2017). GPx-3 is known as the extracellular GPx but 
substrate specificity or substrate affinity is still not well understood (Brigelius-Flohe and 
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Maiorino 2013). As unglycosylated recombinant human GPx-3 mutants expressed in E. coli 
is active as a monomer it might also detoxify large proteins (Song, Yu et al. 2014).  
 
2.8 Iron 
 
2.8.1 Iron homeostasis 
 
Iron is a highly reactive metal in the 8th group of the periodic system (Fanzani and Poli 2017). 
Free iron is toxic to cells, because ferrous iron (Fe II) can react with hydrogen peroxide to 
form a hydroxyl radical and a hydroxide ion. In a second step ferric iron (Fe III) is then 
reduced back to ferrous iron by a second reaction with an additional molecule of hydrogen 
peroxide (Dixon and Stockwell 2014). During this reaction a hydroperoxyl radical and a 
proton are formed (Swaminathan, Fonseca et al. 2007). The two-step iron-catalyzed 
disproportionation of hydrogen peroxide is termed Fenton reaction (Arosio and Levi 2010, 
Dixon and Stockwell 2014, Doll and Conrad 2017). This occurs because ferrous iron has the 
ability to donate electrons, whereas ferric iron is an efficient electron acceptor. Thus, excess 
free iron causes oxidative stress  (Enculescu, Metzendorf et al. 2017). For this reason, iron is 
usually incorporated or bound to molecules (Dixon and Stockwell 2014, Handa, Morgan-
Stevenson et al. 2016). Stored iron in cells is bound to ferritin (Arosio and Levi 2010), 
whereas it is bound to transferrin if it is transported via the blood stream. The vast majority of 
iron in the human body is bound to hemoglobin (Swaminathan, Fonseca et al. 2007, Dixon 
and Stockwell 2014).  
Systemic iron overload harms the organism (Kemna, Tjalsma et al. 2008, Neves, Leitz et al. 
2017) as it changes, e.g. glucose metabolism in a negative way (Handa, Morgan-Stevenson 
et al. 2016). Studies have shown a relationship between systemic iron overload caused by 
hemochromatosis and the risk to develop T2D (Altamura, Kopf et al. 2017). It was also 
monitored that increased iron uptake from nutrients can increase the risk to develop insulin 
resistance (Swaminathan, Fonseca et al. 2007). In contrast, in vivo treatment with the iron 
chelator deferoxamine reduced HbA1c levels in diabetic rats(Roza, Slakey et al. 1994). The 
mechanism how iron induces insulin resistance or how iron contributes to diabetic 
complications remains to be elucidated. The progression of diabetic nephropathy could be 
postponed into the future by supplementation of an iron chelator or with a low iron-containing 
diet.  
Iron homeostasis is tightly regulated by the hormone hepcidin, which is produced in the liver 
(Altamura, Kopf et al. 2017, Enculescu, Metzendorf et al. 2017). Its main function is to bind to 
the iron exporter ferroportin in the membranes of duodenal enterocytes in the gut or to 
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ferroportin in membranes of macrophages (Kemna, Tjalsma et al. 2008, Steinbicker and 
Muckenthaler 2013, Altamura, Kessler et al. 2014, Chen, Feng et al. 2016). Both cell types 
are important to maintain iron homeostasis. Duodenal enterocytes are responsible for iron 
uptake from nutrients, whereas macrophages are responsible for iron recycling, e.g. from 
erythrocytes (Chen, Feng et al. 2016). As iron is essential for the function of most cells but is 
naturally not available in huge quantities, a failure in maintaining iron homeostasis has 
detrimental effects for the whole organism (Swaminathan, Fonseca et al. 2007). Ferroportin 
has a hepcidin binding side (Altamura, Kopf et al. 2017). In terms of high systemic iron 
levels, hepcidin levels are also high. In this case hepcidin binds to ferroportin, ferroportin is 
internalized, ubiquitinylated and degraded (Steinbicker and Muckenthaler 2013, Creighton 
Mitchell and McClain 2014, Chen, Feng et al. 2016, Enculescu, Metzendorf et al. 2017). If 
iron levels are low, hepcidin levels are low as well. Thus, ferroportin is active and transports 
iron into the blood stream (Steinbicker and Muckenthaler 2013, Altamura, Kessler et al. 
2014).  
 
Figure 7: Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. 
From Bogdan, A. R. Trends in Biochemical Sciences (2016, 41). ZRT/IRT-like protein (ZIP) family 
transporters (ZIP8 and ZIP14), non-transferrin bound iron (NTBI), prion protein (PRNP), transferrin 
(Tf), six-transmembrane epithelial antigen of prostate 3 (STEAP3), divalent metal transporter 1 
(DMT1), Poly-(rC)-binding protein 1 (PCBP1), hypoxia-inducible factor (HIF), nuclear receptor 
coactivator 4 (NCOA4). 
There are two ways of iron uptake into cells. Most of the iron uptake occurs via receptor-
mediated endocytosis (Creighton Mitchell and McClain 2014, Bogdan, Miyazawa et al. 2016). 
Thus, the binding of holotransferrin to the transferrin receptor I is necessary (Bogdan, 
Miyazawa et al. 2016). The acidic environment in the early endosome changes the affinity of 
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iron to its receptor (Liu, Sun et al. 2009, Muckenthaler, Rivella et al. 2017). Therefore, the 
ferric iron detaches from the iron-transferrin-transferrin-receptor complex (Creighton Mitchell 
and McClain 2014). Moreover, iron is actively transported via Divalent Metal Transporter 1 
(DMT1) after it is reduced to ferrous iron by a Six Transmembrane Epithelial Antigen of the 
Prostate (STEAP) family member (Kemna, Tjalsma et al. 2008, Bogdan, Miyazawa et al. 
2016). The transferrin-transferrin-receptor complex in the vesicle is transported back to the 
membrane (Bogdan, Miyazawa et al. 2016, Muckenthaler, Rivella et al. 2017). The whole 
complex is released into the blood stream after fusion of the vesicle with the membrane. The 
second possibility to take up iron is the direct uptake via Zinc Transporter Protein 14 (ZIP14) 
or DMT1 (Fanzani and Poli 2017) after it is reduced by a STEAP family member to ferrous 
iron (Creighton Mitchell and McClain 2014). In both cases, iron is immediately stored into 
ferritin or incorporated into a molecule (Bogdan, Miyazawa et al. 2016, Muckenthaler, Rivella 
et al. 2017).  
People with T2D have a significant higher transferrin saturation as well as more stored iron in 
the epithelial cells of the liver (Muckenthaler, Rivella et al. 2017). Systemic iron overload is 
associated with low hepcidin levels and therefore constitutive active ferroportin in the 
duodenal enterocytes in the gut and in macrophages (Steinbicker and Muckenthaler 2013). 
Increased levels of phosphorylated AKT in the liver of db/db mice could inhibit the translation 
of hepcidin mRNA, thus reducing the amount of hepcidin released from the liver into the 
blood stream (Altamura, Kopf et al. 2017).  
 
2.8.2 Ferroptosis in podocytes  
 
Ferroptosis is a recently discovered iron-dependent regulated form of cell death (Doll and 
Conrad 2017, Shah, Shchepinov et al. 2018). It is morphologically and biochemically distinct 
from other regulated cell death pathways as pyroptosis, necroptosis or autophagy (Latunde-
Dada 2017). Ferroptosis is a caspase-independent cell death (Cao and Dixon 2016) and 
executed by a loss of GPx-4 protein abundance or GPx-4 activity (Figure 8), and a 
subsequent accumulation of phosphatidylcholine (PC), phosphatidylethanolamine (PE) and 
cardiolipin (CL) lysoforms (Friedmann Angeli, Schneider et al. 2014, Conrad and Friedmann 
Angeli 2015, Doll and Conrad 2017). All three lysoforms belong to the group of lipid 
hydroperoxides and are mainly detoxified by GPx-4 (Friedmann Angeli, Schneider et al. 
2014, Cozza, Rossetto et al. 2017). An accumulation of these species changes the fluidity 
and the permeability of all kind of cell membranes (Doll and Conrad 2017, Latunde-Dada 
2017).   
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Figure 8: Ferroptosis: Death by Lipid Peroxidation. From Yang WS, Stockwell BR. Trends Cell 
Biology (2016), 26:165-76. GSH (reduced glutathione), GSSG (oxidized glutathione), GPx-4 
(Glutathione peroxidase 4), Fe2+ (ferrous iron) 
 
 
 
 
 
 
 
2.9 Feedback loop 
 
GPx-4 protein abundance is significantly reduced in the glomeruli of human kidneys from 
patients with T2D (Wiedenmann, Dietrich et al. 2018). Moreover, lipid hydroperoxides are 
detoxified exclusively by GPx-4 (Friedmann Angeli, Schneider et al. 2014, Yang, 
SriRamaratnam et al. 2014). Thus, lipid hydroperoxides accumulate in the glomeruli of  
 
Figure 9: Iron accumulation, glutathione depletion, and lipid peroxidation must occur 
simultaneously during ferroptosis and are mutually amplifying Events. From Bertrand, R. L. 
Medical Hypotheses. (2017), February: 69-74. 
 
human kidneys from patients with T2D (Figure 9). Lipid hydroperoxides are highly reactive 
and change the fluidity and the permeability of the cell membranes inter alia the membranes 
of vesicles (Dixon and Stockwell 2014, Bertrand 2017, Doll and Conrad 2017). This can be 
detrimental, because iron import is mainly regulated via transferrin mediated endocytosis. 
Lysosomal membrane permeabilization leads to an uncontrolled release of transferrin-
transferrin-receptor bound iron complexes into the cytoplasm (Doll and Conrad 2017). The 
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pH shift changes the affinity of the transferrin-iron complex which releases the iron. Excess 
cellular iron reacts with non-detoxified hydrogen peroxide (Doll and Conrad 2017). Thus, 
Fenton reaction occurs more often causing glutathione depletion (Bertrand 2017, Latunde-
Dada 2017). After reaching a certain threshold, the activity of the glutathione peroxidases 
gets reduced (Figure 9). 
 
2.10 Mouse Models of T2D and obesity  
 
Leptin (Ob-Rb) receptor-deficient db/db mice develop human type 2 diabetes mellitus 
(Brosius, Alpers et al. 2009). In db/db mice a point mutation leads to premature termination 
of translation of the long cellular domain of the Ob-Rb splice variant and loss of its signal 
transducing function (Lee, Proenca et al. 1996, Han, Isono et al. 2001, Jung, Nam et al. 
2016). As already discussed in chapter 3.3 the Ob-Rb isoform is highly abundant in the 
hypothalamus and contains intracellular motifs required for activation of the JAK/STAT signal 
transduction pathway, which is responsible for the feedback loop required to reduce food 
intake. Obese db/db mice are more than two times as heavy as their wild-type counterparts 
which results in an increased concentration of leptin in the blood. In addition, Ob-Rb 
deficiency leads to the development of hypertension (UK Prospective Diabetes Study Group 
1998). In contrast, the ob/ob mouse model lacks the hormone leptin. Leptin deficiency has 
the same consequence in the hypothalamus as a point mutation in the long leptin receptor 
splice variant Ob-Rb. Thus, the absence of activation of the JAK/STAT signal transduction 
pathway in the hypothalamus, which is responsible for the feedback loop required to reduce 
food intake, also causes the obese phenotype in these mice. In contrast to the db/db mice, 
leptin signaling in general is impaired. This includes also leptin signaling in peripheral organs 
such as the kidney. 
 
3.1 Working hypothesis 
 
For more than a few decades diabetes is defined as the disease with high blood glucose 
concentrations. The unifying hypothesis published by Brownlee turned the initial observation 
that normalization of blood glucose levels with insulin treatment can prevent diabetic late 
complications into a dogma. Unfortunately, insulin treatment can postpone or reduce, but 
cannot prevent the development of diabetic late complications (Falkevall, Mehlem et al. 
2017, Cooper, El-Osta et al. 2018). Thus, we assume diabetes is not a disease, but rather a 
phenotype defined by the biomarker glucose. Instead, most of the patients suffering from 
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T2D are obese. We conclude, that factors related to obesity may play a bigger role and are 
pivotal for the severity and the progression of the disease. The hormone leptin which is 
expressed by white adipose tissue is one of the suspected candidates. Until today it is 
unknown, how leptin resistance develops (Friedman and Halaas 1998, Dam, Jockers et al. 
2015). Moreover, the action of leptin in peripheral organs is not known as well (Han, Isono et 
al. 2001, Honda, Ikejima et al. 2002, De Matteis, Dashtipour et al. 2007, Li, Ceccarini et al. 
2013, Goto, Kaneko et al. 2016). We assume, that even though leptin resistance occurs in 
the brain, it is not implemented in peripheral organs. Thus, in obese people high leptin levels 
provoke high leptin signaling in peripheral organs inter alia the kidney. We also postulate that 
leptin signaling occurs by binding of the ligand leptin to the short leptin receptor splicing 
variant Ob-Ra, rather than to the long leptin receptor splicing variant Ob-Rb at the glomerular 
endothelial cells in the kidney (De Matteis, Dashtipour et al. 2007, Goto, Kaneko et al. 2016). 
Further, glomerular endothelial cells could respond to leptin binding with the 
release/activation of TGF-β1. As glomerular endothelial cells and podocytes are in close 
proximity, we assume a paracrine TGF-β1 signaling between these two cell types. Binding of 
TGF-β1 to TGF-β type I receptors might recruit TGF-β type II receptors causing an activation 
of the downstream cascade leading to the downregulation of GPx-4 protein in the podocytes.  
In parallel an impaired iron homeostasis could influence the activity of GPx-4 in the 
podocytes (Doll and Conrad 2017). In patients suffering from T2D hepcidin levels are lower 
compared to healthy individuals, most likely caused by elevated phosphorylated AKT 
(Altamura, Kopf et al. 2017). Thus, the iron exporter ferroportin in the duodenal enterocytes 
of the gut and in the macrophages is constantly active. Therefore, circulating iron levels are 
high. Iron might accumulate in epithelial cells inter alia podocytes of the kidney.  
The co-action of both the downregulation of GPx-4 in podocytes induced by leptin signaling 
in glomerular endothelial cells and the iron accumulation in podocytes caused by a systemic 
iron overload might trigger a feedback loop, as lipid hydroperoxides are detoxified exclusively 
by GPx-4 (Bertrand 2017). Therefore, we assume that lipid hydroperoxides accumulate in the 
glomeruli of kidneys from patients with T2D. Lipid hydroperoxides are highly reactive and 
change the fluidity and the permeability of the cell membranes inter alia the membranes of 
vesicles (Bertrand 2017). This could be detrimental, because iron import is mainly regulated 
via transferrin mediated endocytosis. Lysosomal membrane permeabilization could lead to 
an uncontrolled release of transferrin-transferrin-receptor bound iron complexes into the 
cytoplasm (Doll and Conrad 2017). The change in pH changes the affinity of the transferrin-
iron complex which could release the iron. Excess cellular iron might react with non-
detoxified hydrogen peroxide (Dixon and Stockwell 2014). Thus, Fenton reaction could occur 
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more often causing a glutathione depletion (Doll and Conrad 2017). After reaching a certain 
threshold, the activity of the glutathione peroxidases could be reduced (Bertrand 2017). 
 
Figure 10: Working hypothesis. Paracrine TGF-β1 signaling between endothelial cells and 
podocytes leads to downregulation of GPx-4 in these cells. In addition, excess iron derived from a 
systemic iron overload spurs the feedback loop driving the podocytes into ferroptosis.  
In addition, a third trigger could be needed to activate the feedback loop. As hyperglycemia is 
associated with diabetes, high glucose levels might be able to trigger or enhance the vicious 
cycle described above (Latunde-Dada 2017). A detrimental accumulation of lipid 
hydroperoxides could trigger the programmed cell death pathway ferroptosis in podocytes, 
which possibly explains the loss of these cells during the progression of the disease (Cao 
and Dixon 2016).  
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3.2 Aims 
 
The aim of this study was to show that hyperglycemia itself is not the main reason for 
developing diabetic nephropathy but rather a concomitant phenomenon pivotal to induce a 
self-reinforcing feedback loop driving the inactivation of GPx-4. Thus, the following aspects 
were covered in this thesis: 
• Quantification of leptin receptor transcripts in endothelial cells: 
The transcripts of the leptin receptor Ob-Rb, Ob-Ra and Ob-Rc were analyzed in two 
different microvascular endothelial cell types. The quantification of the leptin receptor 
splice variants will indicate the contribution to a downstream signaling.   
 
• Analysis of endothelial cell and podocyte interaction: 
Endothelial cells and their respective supernatant medium were collected after leptin 
stimulation. The following activation/release of TGF-β1 seemed to play a major role 
by reducing GPx-4 protein abundance in podocytes. As both cell types are in close 
proximity, a possible paracrine TGF-β1 signaling was analyzed.  
 
• Quantification of GPx-4 protein abundance and iron accumulation in mouse 
models of T2D: 
The impact of leptin signaling and systemic iron overload was analyzed ex vivo by a 
quantification of the amount of GPx-4 protein and the amount of iron in the glomeruli 
of db/db, db/db/fpn+/- mice and leptin-deficient ob/ob mice.   
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4. Materials 
4.1. Cell culture 
CryoStor® CS10 Freeze Media, PeloBiotech, PB-210102 
Gelatin-based coating solution, Cell Biologics, 6950 
Falcon 12-well plate, neoLab, 353503 
Falcon 6-well plate, neoLab, 353502 
Transparent PET Membrane 12 Well 0.4 µM pore size, neolab, 353180 
Transparent PET Membrane 6 Well 0.4 µM pore size, neoLab, 353090 
 
4.1.1. Cell lines and primary cells 
 
C57BL/6 Mouse Primary Kidney Glomerular Endothelial Cells, PeloBiotech, PB-C57-6014G 
Conditionally immortalized murine microvascular endothelial cells, InSCREENeX, INS- CI-
1004 
E11 podocytes, Cell line services, 400494 
 
4.1.2 Cytokines, enzymes and inhibitors  
0.25 % Trypsin-EDTA, Cell Biologics, 6914 
(1S, 3R)-RSL3, Cayman Chemical, 19288 
Apo-Transferrin human, Sigma-Aldrich, T1147-100MG 
Erastin, Merck Millipore, 329600-5MG 
LY2109761, Cayman Chemicals, 700874-71-1 
Nitrilotriacetic acid disodium salt, Sigma-Aldrich, N0128-100MG 
Recombinant murine leptin, PeproTech, AF-450-31 
rm IFN-gamma recombinant mouse protein, Thermo Fischer, PMC4031 
TGF-β 1,2,3 antibody, R&D Systems, MAB1835-500 
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Transferrin, Holo, Human Plasma, Merck Millipore, 616424 
Trypsin-EDTA, Thermo Scientific, 25200056 
 
4.1.3 Media 
 
Co-culture medium DMEM (1x) + GlutaMAX, gibco, 21885-025 
5 % fetal calf serum (FCS), 35 nM Na2SeO3, 1 % NEAAs, 0.5 % ECGS, 0.02 % 
Fungizone and 1 % Penicillin/Streptomycin 
DMEM (1x) + GlutaMAX, gibco, 21885-025 
10% fetal calf serum (FCS), 35 nM Na2SeO3, 1% NEAAs, 0.5% ECGS, 0.02% 
Fungizone and 1% Penicillin/Streptomycin 
RPMI 1640 Medium (no glucose), Thermo Fischer, 11879-020 
10 % fetal calf serum (FCS), 5 mM Glucose, 35 nM Na2SeO3, 0.02 % Fungizone and 
1 % Penicillin/Streptomycin 
Mouse Endothelial Cell Medium, PeloBiotech, PB-M1168 
 
4.1.4 Media supplements 
 
ECGS, Promo Cell, C-30120 
FCS, Thermo Scientific, 10500-064, LOT 08G7661K 
Fungizone, gibco, 15290-018 
Glucose, Merck Millipore, 8337 
NEAAs, gibco, 11140-035 
Penicillin/Streptomycin, Thermo Fischer, 15140122 
 
4.2 Protein analysis 
Bradford-Reagent, Bio-Rad, 500-0006 
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Cartrige: 12-230 kDa, Biotechné, SM-W004-1 
Filter paper, Neolab, 2-4325 
Protein-Standard, Bio-Rad, 161-0374 
PVDF membrane, Merck Millipore, ISEQ00010 
SDS Sample buffer, Carl Roth, K929.1 
Standard Pack 1, Bio-Techne, PS-ST01-8 
Wes Cartridges, Bio-Techne, SM W004-1 
 
4.2.1 Inhibitors 
 
Dithiothreitol (DTT), Sigma-Aldrich, 10197777001 
Halt Protease & Phosphatase cocktail, Thermo Scientific, 78442 
Leupeptin hemisulfate salt, Sigma-Aldrich, L5793 
Pefabloc, Sigma-Aldrich, 76307 
Pepstatin A, Sigma-Aldrich, P5318 
 
4.3 Isolation of primary cells 
Collagenase A, Roche Diagnostics, 10103586001 
Desoxiribonuclease I, Invitrogen, 18047019 
Dynabeads® M-450 Tosylactivated, Thermo Fischer Scientific, 140.13 
Ketamin 10 %, MEDISTAR Arzneimittelvertrieb GmbH, 03048734   
Xylavet (Xylazin) 20 mg/mL, CP-Pharma, 1205 
 
4.4 ELISA 
Amicon Ultra-0.5 Centrifugal Filter-10 K, Merck Millipore, UFC501024 
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TGF-β1 ELISA Kit (mouse), PromoKine, PK-EL-63506M 
 
4.5 Antibodies 
4.5.1 Western Blot 
 
Primary antibodies 
Mouse anti-ß-actin antibody, abcam, ab6276, 1:5000 in blocking solution 
Rabbit anti-GPx-1 antibody, GeneTex, 116040, 1:1000 in blocking solution 
Rabbit anti-GPx-4 antibody, abcam, ab125066, 1:1000 in blocking solution  
 
Secondary antibodies 
Anti-mouse- IgG-HRP, Sigma Aldrich, A4416, 1:5.000 in blocking solution 
Anti-rabbit- IgG-HRP, Sigma Aldrich, A6154, 1:3.000 in blocking solution 
 
4.5.2 Simple WES 
 
Primary antibodies 
Goat anti-GPx-3 antibody, Biotechné, AF4199, 1:60 
Mouse anti-ß-actin antibody, abcam, ab6276, 1:1000 
Rabbit anti-GPx-1 antibody, Biotechné, AF3798, 1:30 
Rabbit anti-GPx-4 antibody, abcam, ab125066, 1:75 
 
Secondary antibodies 
Anti-rabbit detection Module, Biotechné, DM-001, 1:20 
 
Anti-mouse detection Module, Biotechné, DM-002. 1:20  
 
Anti-rabbit HRP conjugate (20x), Biotechné, 043-426, 1:20 
 
Donkey anti-goat secondary HRP conjugate, Biotechné, 043-522-2, 1:50 
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4.5.3 Histology 
 
Primary antibodies 
Anti-CD 31, Santa Cruz, SC-18916, 1:50 
Anti-GPx-4, abcam, ab125066, 1:100 
Anti-synaptopodin antibody (P-19), Santa Cruz, sc-21537, 1:100 
 
Secondary antibodies 
Donkey anti-goat-Cy2, Dianova, 705-546-147, 1:100 
Donkey anti-goat-Cy3, Dianova, 711-166-147, 1:100  
Donkey anti-goat-Cy5, Dianova, 711-175-147, 1:100 
Donkey anti-rabbit-AlexaFluor488, Dianova, 712-545-153, 1:100  
Donkey anti-rabbit-Cy3, Dianova, 711-166-152, 1:100  
Donkey anti-rat-Dylight549, Dianova, 712-505-153, 1:100  
 
 
Additional dyes 
4',6-Diamidin-2-Phenylindol (DAPI), Invitrogen, D1306 
SYBR Green, Qiagen, 204145 
 
1.6 Buffers 
Buffer for the isolation of primary podocytes 
Buffer 1: 62.1 mg NaH2PO4xH20, 638.8 mg Na2HPO4, H2O ad 50 mL, pH 7.4-8.0 
Buffer 2: 37.2 mg EDTA, 50 mg BSA, PBS ad 50 mL, pH 7.4 
Buffer 3: 1.21 g Tris, 50 mg BSA, H20 ad 50 mL, pH 8.5 
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Homobuffer (25 mM Tris-HCL (pH 7.4), 0.55% KCL, 1 mM EDTA, 2.5 mM Glucose, 0.1 mM 
DTT, 80 µg/mL Pefabloc, 6 µg/mL Pepstatin A and 6 µg/mL Leupeptin) 
 
RIPA buffer, Sigma Aldrich, R0278  
RotiR-Load 1 (4x), Roth, K929.1 
Running buffer (24.8 mM Tris-HCL (pH 8.3), 192 mM Glycin, 3.5 mM SDS, H2O ad 1 L)  
TBE buffer (90 mM Tris, 90 mM boric acid, 2 mM EDTA) 
TBS (50 mM Tris-HCL (pH 7.5), 150 mM NaCl, H2O ad 1L) 
TBS-T (50 mM Tris-HCL (pH 7.5), 150 mM NaCl, 0.05 % Tween, H2O ad 1 L) 
Transfer buffer (24.8 mM Tris-HCL (pH 8.3), 192 mM Glycin, H2O ad 800 mL), 20 % 
methanol 
and 0.05 % SDS 
WES-RIPA-buffer (25 mM Tris-HCL, pH 7.6, 15 mM NaCl, 1 % NP-40, 1 % sodium 
deoxycholate, 0.1 % SDS) 
PBS was purchased from Thermo Fisher Scientific (10010023). 
 
4.7 Solutions 
Acrylamide (Rotiph. / 37, 5:1), 3029.1 
Eukitt, Kindler 
FeNTA (40 mM Nitrilotriacetic acid disodium salt and 10 mM FeCl3) 
Luminata Classico, Merck Millipore, WBLUC0100 
Luminata Forte, Merck Millipore, WBLUF0100 
Mowiol, Calbiochem, 475904 
Paraformaldehyde (PFA), Sigma Aldrich, P6148 
Schiff's reagent, Merck Millipore, 1090340250 
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4.8 Chemicals 
β-Mercaptoethanol, Sigma Aldrich, M6250 
Ammoniumpersulfat (APS), Carl Roth, 9592.5 
BSA, Carl Roth, 8076.2 
EDTA, Applichem, A1103.0250 
Natriumselenit, Sigma Aldrich, 214485 
SDS, Serva Electrophoresis, 20767  
Tetramethylethylendiamin (TEMED), Carl Roth, 2367.1 
Tris, Carl Roth, 4855.2 
TritonX100, Sigma Aldrich, T8787 
Tween20, Carl Roth, 9127.1 
 
4.9 Anesthesia 
Xylazin/Ketamin Mix: 560 µl NaCl 0.9%, 150µl Ketamin and 90µl Xylazin 
 
4.10 Additional kits 
Omniscript RT Kit, Qiagen, 205111 
 dNTPs, Bioron, 110011 
RNAse inhibitor, Promega, N251B 
OligodT primer, Promega, C110A 
PerOx (TOS/TOC) Kit, Immundiagnostik, KC5100 
PierceTM BCA Protein Assay Kit, ThermoScientific, 23225 
RNeasy Mini Kit, Qiagen, 74106 
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4.11 Equipment 
ImageQuant LAS 4000 mini, GE Healthcare 
Rotor-Gene Q thermocycler, Qiagen 
Microscope, CellSens-Olympus (Ix-3) 
Microscope, Xellence (rt) – Olympus (Ix-2) 
NanoDrop ND1000, NanoDrop Technologies 
Simple WES, Bio-Techne, W82844 
Tissue lyser, Retsch, MM301 
UP50H Ultrasonic Processor, Hielscher Ultrasonics 
 
4.12 Programs 
GraphPad Prism, version 7.02 
ImageJ, version 1.4.3.67 
QuPat, version 0.1.2 
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5. Methods 
5.1 Animals 
All animal experiments were performed with permission of the Regional Council Karlsruhe 
(G53/17) and in accordance with institutional and governmental guidelines. Kidneys were 
taken from wild-type (wt) mice or from db/db mice (B6.BKS(D)-Leprdb/J) after the mice had 
been sacrificed with CO2, immediately frozen in liquid nitrogen and stored at -80 degrees 
Celsius until they were used for tissue slides or tissue homogenates. For podocyte isolation 
kidneys were taken from wt mice after intraperitoneal injection with a Ketamine/Xylazine mix 
and perfusion with PBS containing tosylactivated dynabeads.  
Db/db mice (B6.BKS(D)-Leprdb/J), heterozygous littermates, homozygous Slc40a1C326S/C326S 
mice as well as heterozygous Slc40a1wt/C326S on a db/db mouse (B6.BKS(D)-Leprdb/J) 
background were kindly provided by Prof. Martina Muckenthaler and Dr. Sandro Altamura 
(University of Heidelberg, Department of Pediatric Hematology, Oncology and Immunology). 
Ob/ob mice (BTBR.Cg-Lepob/WiscJ) as well as their homozygous littermates were kindly 
provided by Prof. Benito Yard (Medical Faculty Mannheim of the University of Heidelberg, 
Department of Nephrology, Endocrinology and Rheumatology). 
 
5.2 Isolation of primary podocytes 
The following method is based on the perfusion of mice with PBS containing tosyl-activated 
dynabeads, which get stuck in the kidney glomeruli and subsequently isolated after 
homogenization of the kidney by using a magnetic particle concentrator (Katsuya, Yaoita et 
al. 2006). Isolated glomeruli are seeded afterwards on gelatin-coated petri dishes in 
podocyte specific medium. Podocytes grow out of the glomeruli after they have settled and 
attached to the gelatin-coated petri dish. The podocytes were passaged before the podocyte 
islands started to touch each other.  
Magnetic beads were prepared one day before the isolation. Therefore 200 µl beads per 
mouse were washed with 1 mL buffer for 1 min in the magnetic particle concentrator. The 
beads were resuspended in 200 µl buffer 1 and washed again. In the next step, beads were 
washed twice with 200 µl buffer 2 for 5 min on ice. Finally, beads were incubated in 200 µl 
buffer 3 for 24 hours at room temperature on a rotating platform.  
On the next day beads were washed once in 200 µl buffer 2 for 5 min on ice, resuspended in 
200 µl buffer 2 and kept on ice until they were utilized. Before they were added to the PBS 
the beads were resuspended thoroughly. Mice were anaesthetized by intraperitoneal 
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injection of xylazin/ketamin mix (200 µl for 30 g wt or 600 µl for 65 g db/db mice). The thorax 
was opened while the diaphragm was detached from the rips. The coastal arch was opened, 
and the liver was cut several times before perfusion. The mouse was perfused through the 
left ventricle with 20 mL PBS containing 8x107 tosylactivated dynabeads at a speed of 600 
mL per hour. The dynabeads got caught in the kidney glomeruli. The kidneys were removed, 
transferred into an ice-cold PBS-containing tube and minced into 1 mm3 pieces by pressing 
them gently through a 100 µm cell strainer. In the next step the kidney homogenate was 
digested in 20 mL collagenase A in PBS (1 mg/mL Collagenase) at 37 degrees Celsius for 
30 min with DNase (100 U/ µl). After the first digestion the kidney homogenate was pressed 
through a 40 µm cell strainer and centrifuged at 200 g for 5 min. The pellet was resuspended 
in 1.8 mL of PBS in an Eppendorf tube, placed later on in a magnetic particle concentrator for 
at least 2 min to gather the glomeruli containing dynabeads. After three washing steps the 
homogenate was digested in 2 mL collagenase A (1mg/mL) for 30 min at 37 degrees Celsius 
and centrifuged at 1000 rpm for 5 min at 5 degrees Celsius. The pellet was resuspended in 1 
mL of RPMI medium and plated on gelatin-coated petri dishes (2% gelatin).  
 
5.3 Immunofluorescence 
To assure the purity of the respective cell populations and the degree of their differentiation, 
their specific marker expression was determined and visualized with an antibody coupled to 
a fluorescent dye. The integral membrane glycoprotein CD31, also known as platelet 
endothelial cell adhesion molecule-1 (PECAM-1), was chosen as an endothelial cell specific 
marker. Differentiated E11 podocytes and primary podocytes express synaptopodin at their 
foot processes which was selected as podocyte specific marker. 
E11 podocytes or primary podocytes were cultivated in 12 well plates and washed two times 
with PBS before they were fixated for 30 min with 2 % paraformaldehyde. After an additional 
washing step, cell membranes were permeabilized for 5 min with 0.3 % TritonX100 in PBS 
and washed again with PBS. Primary glomerular endothelial cells (PeloBiotech) and CI-
muMECS were cultivated in 96 well plates and washed twice with PBS before they were 
fixated with ice cold methanol for 10 min. After the fixation step they were washed again with 
PBS. The respective cells were incubated for 1 hour with 5 % bovine calf albumin (BCA) 
independent of the fixation method to block unspecific antibody binding sides. Podocytes 
were stained subsequently in a wet chamber for synaptopodin and endothelial cells for CD31 
for 1 hour at room temperature. After an additional washing step (with PBS) cells were 
incubated for 1 hour with the secondary antibody coupled to a fluorescent dye. The cells 
were stained with DAPI for 8 min in order to visualize the nuclei. After the last washing step 
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(with PBS) cells were embedded in mowiol, covered with a cover slip and dried over night at 
4 degrees Celsius. On the next day marker expression was determined using the 
fluorescence microscope (CellSens-Olympus). First and secondary antibodies were diluted in 
blocking solution as described above. 
 
5.4 Cell culture 
5.4.1 E11 podocytes 
 
For cell culture experiments the murine kidney podocyte cell line E11 was proliferated at 33 
degrees Celsius with 50 U/mL IFN-γ added into the medium (RPMI). The E11 podocytes 
contain a temperature sensitive variant of the SV40T-antigen with an IFN-γ inducible 
promoter. Under differentiation conditions, i.e. incubation of non-confluent cultures at 37°C 
without IFN-γ, cell proliferation ceases within the first two weeks. After 14 days of 
differentiation E11 cells were used for further experiments. 
To determine the amount of GPx-1 and GPx-4 protein in E11 podocytes, these cells were 
incubated with different leptin concentrations (5 to 200 ng/mL) as well as different TGF-β1 
concentrations (1 to 50 ng/mL) and harvested after 5 days of treatment. In order to quantify 
GPx-4 protein abundance in a time dependent manner, E11 podocytes were stimulated for 5 
days with 30 ng/mL recombinant TGF-β1 and harvested every 24 hours. On day 3 the old 
medium was removed and replaced by new medium (with TGF-β1). To test the influence of 
iron apotransferrin (30 µM), holotransferrin (30 µM) or FeNTA (10 mM iron) was added into 
the medium of E11 podocytes and into the medium of E11 podocytes stimulated with 30 
ng/mL recombinant TGF-β1 for 5 days. To inhibit GPx-4 activity E11 podocytes were 
stimulated with 10 µM erastin or 25 µM RSL-3 for 3 days.  
 
5.4.2 Primary podocytes 
 
Isolated glomeruli have settled for 48 hours on gelatine-coated petri dishes (3 cm). RPMI-
medium was gently removed and replaced by new medium. 9 - 11 days post isolation 
primary podocytes (p0) were trypsinized. Primary podocytes adhere firmly to the gelatine-
coated petri dish, therefore 2 mL trypsin EDTA was added after washing two times with -/- 
PBS. Trypsin EDTA was quickly removed before primary podocytes were incubated with new 
2 mL trypsin EDTA for 30 min. The enzymatic reaction was stopped by adding medium to the 
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cells. Subsequently the cell suspension was centrifuged at 200 g for 5 min. The pellet was 
resuspended in new medium and plated on gelatine coated petri dishes (10 cm). 20 - 25 
days post isolation primary podocytes (p1) were trypsinized again as described above. The 
cell suspension was plated on non-gelatine-coated 6 well plates or 12 well plates. 30 - 35 
days post isolation primary podocytes (p2) were taken for experiments. In order to quantify 
GPx-4 protein abundance in a time dependent manner, primary podocytes were stimulated 
for 5 days with 30 ng/mL recombinant TGF-β1 and harvested every 24 hours. On day 3 the 
old medium was removed and replaced by new medium (with TGF-β1). 
 
5.4.3 CI-muMECS 
 
Conditionally immortalized murine microvascular lung endothelial cells (CI-muMECS (INS-CI-
1004) were provided by InSCREENeX GmbH (Braunschweig. Germany). These cells retain 
many characteristic features of native ECs such as shear stress-induced up-regulation of 
NOS3 and down-regulation of GPx1 expression as well as NO production measured as 
nitrate in the medium/supernatant (Sachdeva, Fleming et al. 2019).  CI-muMECS were 
cultivated in DMEM in gelatin-coated flasks. Every 2 - 3 days cells were split in a ratio 1:3 to 
1:5.  
In order to measure the amount of TGF-β1 mRNA and to quantify active TGF-β1 in the 
supernatant of CI-muMECS, these cells were cultured in 5 % DMEM in 12 well plates until 
they reached 100 % confluence and were stimulated with different concentrations of leptin 
(10-1000 ng/mL leptin) for 24 hours. The cells were lysed with RLT-buffer containing 1 % β-
mercaptoethanol, whereas the supernatant was collected and spent for a TGF-β1 ELISA. To 
determine the expression of the different leptin splice variants, CI-muMECS were cultured in 
5 % DMEM in T75 flasks until they reached 100 % confluence and were lysed with RLT-
buffer containing 1 % β-mercaptoethanol.  
 
5.4.4 Primary glomerular endothelial cells 
 
Primary glomerular endothelial cells purchased from PeloBiotech were cultivated in mouse 
endothelial cell medium in pre-coated T25 flasks until they reached 80 - 90 % confluence. 
Cells were washed 2 - 3 times with -/- PBS and incubated with 2 mL warm 0.25 % Trypsin-
EDTA solution for 4 min. As soon as cells detached from the flask, 8 mL medium were added 
to the trypsinized cells, gently resuspended and immediately plated on fresh flasks pre-
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coated with gelatin-based coating solution. Primary glomerular endothelial cells were always 
splitted 1:2. On the next day the medium was gently replaced by new medium. After 
additional 24 hours the cells were washed with PBS and new medium was added to the 
cells. Medium was replaced every two days until cells reached a density of 70 %. Medium of 
primary glomerular endothelial cells between 70 and 90 % confluence was replaced on a 
daily basis. Primary glomerular endothelial cells were used not later than passage 9. Low cell 
passages were frozen in Cryostor at -80 degrees Celsius. Cells were grown until they were 
100 %% confluent and then used for further experiments.  
 
5.4.5 Co-culture of CI-muMECs and E11 podocytes  
 
In order to establish the co-culture system CI-muMECs were co-cultured with E11 podocytes. 
At later time points primary glomerular endothelial cells were either co-cultured with E11 
podocytes or with primary podocytes.  
  Thus, E11 podocytes were plated in 6-well plates and cultivated in RPMI 5 days before the 
experiment started. CI-muMECS on the other hand have been plated on coated 6-well 
inserts 24 hours before the co-culture experiment started. As podocytes, endothelial cells 
were also grown in their respective medium. E11 podocytes and CI-muMECs were co-
cultured 5 days in co-culture medium as shown in figure 11. At experimental day 3, inserts 
with endothelial cells were replaced by new ones. In addition, medium of the inserts (1 mL), 
but not of the wells (2 mL), was changed. Endothelial cells were stimulated with 100 ng/mL 
leptin or with 30 ng/mL TGF-β1 as a reference stimulus. Primary podocytes were plated in 
12-well plates and cultivated in RPMI 9 days before the experiment started. Glomerular 
endothelial cells on the other hand have been plated on coated 12-well inserts 7 days before 
the experiment started and were grown in their respective medium. Primary podocytes and 
primary glomerular endothelial cells were subsequently co-cultured 5 days in co-culture 
Figure 11: Transwell co-culture system modified from Kumar et al. Vascular Cell (2011), 3:27. 
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medium. Endothelial cells were stimulated with 100 ng/mL leptin or with 30 ng/mL TGF-β1 as 
a reference stimulus. 
 
5.5 ELISA of CI-muMEC supernatant  
The enzyme-linked immunosorbent assay (ELISA) is an analytical biochemistry assay 
applied to detect the presence of active TGF-β1 in the media of cultured endothelial cells. 
The assay resulted in the formation of a colored product, which was formed proportionally to 
the amount of TGF-β1 present in the sample.  
Endothelial cells (cell line CI-muMECs) were cultured in 5 % DMEM in 12 well plates until 
they reached 100 % confluence and were stimulated with different concentrations of leptin 
(10-1000 ng/mL leptin) for 24 hours. Medium (500 µl volume) was collected and 
concentrated with amicon ultra centrifugal filters (MWCO 10 kDa). 20 µl out of 40 µl 
concentrate were spent for a TGF-β1 ELISA according to the manual of the manufacturer. 
The assay used a TGF-β1 antibody coated surface to capture active TGF-β1 present in the 
media. In the next step a biotin-conjugated anti-mouse TGF-β1 antibody was added and 
bound to mouse TGF-β1 attached to the first antibody. After a washing step streptavidin-HRP 
was added and bound to the biotin-conjugated anti-mouse TGF-β1 antibody. Before 
substrate solution reactive with HRP was added to the wells an additional washing step was 
applied. The wells were incubated with TMB substrate in the dark for exact 40 min and 
stopped by quickly pipetting acid to the respective wells. The absorbance at a wave length of 
450 nm was measured immediately at 450 nm. The absorbance at a wave length of 620 nm 
was used as the reference wave length. Data with significant different values at 620 nm were 
excluded. TGF-β1 concentration was determined by the implementation of a standard curve. 
 
5.6 Bradford Assay 
To determine the protein concentration the colorimetric protein assay Bradford was 
performed. This assay is based on the absorbance shift of the dye Coomassie Brilliant Blue 
from 465 nm to 595 nm by binding specifically to aromatic and basic aminoacids, e.g. arginin, 
in the sample. The amount of light absorption is proportional to the amount of proteins in the 
sample. 
To measure the protein concentration podocytes (cell line E11) were harvested with a cell 
scraper in 1 mL PBS and centrifuged at 1.100 g for 5 min. Subsequently pellets were 
resuspended in 70 µl homobuffer and sonicated 3 times for 10 sec. Cell suspensions were 
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cooled on ice between sonification steps. Lysed cells were centrifuged at 1.100 x g for 5 min 
and supernatant was transferred immediately into a new Eppendorf tube. The samples were 
diluted 1:25 to 1:100. 80 µl of the diluted protein homogenate was mixed with 200 µl Bradford 
reagent. The absorption at 595 nm was measured with a photometer. The exact protein 
concentration was determined based on a protein standard concentration row of BSA (5, 10, 
15, 20 und 30 µg/mL).  
 
5.7 SDS–polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE is a standard method to separate proteins in an electric field by size. SDS is 
highly negatively charged, binds to the denatured proteins and forms negatively charged 
SDS-protein complexes. This guarantees a separation only by size and not by any protein 
specific characteristic properties, e.g. tertiary structure. The proteins were translocated in the 
electric field of the acrylamide gel matrix. The velocity of the proteins is proportional to their 
respective size. Bigger proteins get stuck in the matrix and take longer to translocate to the 
anode, whereas smaller proteins can move faster through the gel matrix.  
For this purpose, 15 µg protein were denatured with sodium dodecyl sulfate (SDS) and beta-
mercaptoethanol for 5 min at 95 degrees Celsius and separated in a discontinuous 
electrophoresis system. A 4 % stacking gel (Millipore water, 0.5 M TRIS-HCL, pH 6.8, 0.3 % 
Acrylamide, 10 % SDS, 10 % APS, TEMED) ensured the formation of protein stacks 
according to the principle of isotachophoresis. The separation itself occurred on the 12% 
running gel (Millipore water, 1.5 M TRIS-HCL, pH 8.8, 0.1 % Acrylamide, 0.1 % SDS, 0.1 % 
APS, 0.1% TEMED). Both gels differ in their pH, ion strength and pore size. To identify the 
exact size of the protein the above-mentioned protein standard was loaded next to the 
samples. For protein stacking 80 volts were applied for 30 min, whereas 120 volts were 
applied for 90 min to separate the proteins by their respective size in a gel chamber filled 
with running buffer.  
 
5.8 Western Blot  
In order to visualize and quantify the respective proteins they had to be transferred from the 
SDS PAGE gel (1.5 mm) onto a polyvinylidene difluoride (PVDF) membrane (0.2 µm pore 
size). A wet electroblotting (Tank transfer) chamber was chosen to transfer the proteins. As 
soon as the proteins were immobilized onto the PVDF membrane they were accessible to 
antibody detection visualized via luminescence reaction.  
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At first, the PVDF membrane was activated with methanol for 10 min, washed three times 
with millipore water and equilibrated in transfer buffer. The gel was then placed as a 
sandwich (filter paper-gel-membrane-filter paper) between platinum wire electrodes in a tank 
filled with transfer buffer for 40 min at 350 mA. After blotting the PVDF membrane was 
washed with Millipore water and dried for at least 1 hour at 50 degrees Celsius. The PVDF 
membrane was reactivated with methanol for 10 min, washed three times with millipore water 
and blocked for 1 hour with 5 % Blotto in 1x TBS to block unspecific antibody binding sites. 
Subsequently they were incubated with the first antibodies (GPx-1, GPx-4 and β-actin) in 
blocking solution over night at 4 degrees Celsius. At the next day the membranes were 
washed 3 times with TBST and incubated for 1 hour with the horseradish peroxidase (HRP)-
conjugated secondary antibodies. After additional 2 washing steps with TBST and a washing 
step with TBS the membranes were incubated with the respective HRP-substrates. For β-
actin Luminata Classico and for GPx Luminata Forte was added to the PVDF membranes to 
visualize specific antibody bound proteins via a luminescence detection system. The size of 
the protein bands were quantified with the open-source program ImageJ, whereas the 
amount of GPx-1 and GPx-4 protein was normalized with the amount of β-actin protein.  
 
5.9 BCA Assay (Pierce) 
To determine the exact protein concentration for the simple WES protein detection and 
quantification method the colorimetric two-component, high-precision BCA Protein Assay 
was performed. It combines the well-known reduction of Cu2+ to Cu+ by protein in an alkaline 
medium with the highly sensitive and selective colorcolorimetric detection of the cuprous 
cation (Cu+) by bicinchoninic acid.  
Podocytes (cell line E11) grown in a 12 well plate were therefore harvested with a cell 
scraper in 1 mL PBS, centrifuged at 1.100 g for 5 min and frozen at -80 degrees Celsius. On 
the next day pellets were thawn on ice and resuspended in 25 µl WES-RIPA buffer (with 
protease and phosphatase inhibitors) and vortexed vigorously. After 15 min incubation on ice 
samples were vortexed every 2 min for addional 15 minutes on ice. In the next step samples 
were centrifuged at 1.100 g for 5 min at 4 degrees Celsius. The supernatant was transferred 
into a new eppendorf tube and centrifuged a second time at 5.133 x g for 10 min at 4 
degrees Celsius. The supernatant was transferred again into a new eppendorf tube and was 
frozen at -80 degrees Celsius. On the next day samples as well as standards (25, 125, 250, 
500, 750, 1000, 1500, 2000 µg/mL) were thawn on ice and vortexed. WES-RIPA-buffer was 
used to blank the system. The working reagent was prepared according to the 
manufacuture’s protocol. Protein samples were diluted in a dilution series (1.5, 1:7 and 1:10) 
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in WES-RIPA-buffer. Subsequently 25 µl of each sample and each standard were pipetted in 
two rows onto a 96-well plate. 200 µl working reagent was added to each well and 
resuspended thouroughly. The higher the amount of protein in the sample the darker the 
purple in the respective well. After 30 min at 37°C the absorption at 562 nm was measured 
with a photometer. 
 
5.10 Simple WES analysis of E11 podocytes 
The simple WES is a gel-free capillary-based immunoassay to separate and analyse low 
amounts of proteins. 3 µl starting material is enough to separate proteins by size from 2-440 
kDa. For this reason the simple WES approach was applied for podocyte protein analysis 
derived from co-culture experiments in 12 well plates. Up to 25 samples could run at a time 
and be quantified afterwards.  
At the beginning 10x sample buffer was diluted 1:100 in RNAase free water. In order to 
prepare 400 mM DTT solution, 40 µl of deionized water was pipetted into the DTT containing 
tube provided by the manufacturer. 20 µl of the 400 mM DTT solution was added into the 
fluorescent 5x master mix tube also provided by the manufacturer together with 20 µl 10x 
sample buffer. The ladder was prepared by pipetting 20 µl of deionized water to the 
biotinylated ladder containing tube also provided by the manufacturer. For each capillary a 
total volume of 10 µl of the respective primary antibody dilution as well as a total volume of 
10 µl of the respective secondary antibody dilution was prepaired. Diluted antibodies were 
kept on ice until they have been used. Protein samples suspended in WES-RIPA-buffer were 
carefully thawed on ice. The concentrations of the different protein samples were adjusted 
with WES-RIPA-buffer to a temporary working concentration between 0.2 and 2 µg/µl protein. 
The temporary working dilution was then further diluted with the same volume of 0.1x sample 
buffer. Subsequently 5 µl of diluted protein suspension were spent for each capillary with a 
final protein concentration between 0.2 and 0.8 µg/µl. Therefore 5 µl of the diluted protein 
suspension were mixed with 1.2 µl of fluorescent master mix, transferred into a new 
eppendorf tube, vortexed thouroughly and boilt for 5 min at 95 degrees Celsius. After cooling 
on ice samples were vortexed vigorously and centrifuged for a few seconds. Finally, samples 
were vortexed gently and could be pipetted onto the WES plate according to the 
manufacture`s protocol. We used 4 µl instead of 3 µl prepared samples, 9 µl instead of 10 µl 
primary antibody and 9 µl instead of 10 µl secondary HRP conjungate. Before pipetting row 
E, 200 µl luminol and 200 µl peroxide were mixed and used immediately, because luminol-
peroxide mix is proned to activity loss starting after 15 min of mixture. In the next step the 
WES plate was centrifuged at 1,100 g for 5 min. 500 µl wash buffer was added to the first 
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three rows. The WES plate was placed into the WES reader with the following setting (Table 
1).  
 
 
 
 
5.11 Messenger RNA isolation 
For mRNA extraction the RNeasy Mini Kit was applied as a purification method to isolate 
purify mRNA from either cells (E11 podocytes, CI-muMECs or primary glomerular endothelial 
cells) or from tissue obtained from wildtype or db/db mice.  
Tissue was lysed in 750 µl RLT-buffer containing 1 % β-mercaptoethanol and homogenized 
for 90 sec at 30 Hz with a tissue lyser. Lysed whole kidney homogenate was mixed with the 
same volume 70 % ethanol and loaded onto the RNA columns. The cultivated cells were 
washed with PBS and lysed in 500 µl RLT-buffer containing 1 % β-mercaptoethanol per well. 
Lysed cells were mixed with the same volume 70 % ethanol, harvested using a cell scraper 
and also loaded onto the RNA columns. The RNA was purified according to the protocol of 
the manufacturer. The purified RNA was eluted in 20 µl RNAse free water and stored at -80 
degrees Celsius. 
 
5.12 Copy DNA synthesis 
For the synthesis of DNA the single stranded RNA purified with the RNeasy Mini Kit had to 
be reversely transcribed into complementary DNA (cDNA). Oligo(dT) primers amplify mRNAs 
containing a poly(A) tail at the 3’ end, since that is where the primer binds to promote reverse 
transcription by the reverse transcriptase   
Before cDNA synthesis the concentration of the RNA was determined with a photometrical 
method using a NanoDrop spectrophotometer. 1 µg RNA was transcribed into cDNA by 
adding OligodT primer, dNTPs, RNAse inhibitors and und reverse transcriptase according to 
the protocol of the Omniscript RT Kit. After incubation for 1 hour at 37 degrees Celsius 
samples were stored at -20 degrees Celsius. 
 
Separation time       25 min 
Separation voltage   375 volts 
Antibody diluent time         5 min 
Primary antibody time       90 min 
Secondary antibody time       30 min 
Table 1: WES program to separate and analyze proteins 
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5.13 Quantitative real time polymerase chain reaction (q-PCR) 
The combination of reverse transcription of a RNA template and quantitative real time 
polymerase chain reaction improves the capability to detect low abundance RNAs in the 
samples. The qRT-PCR approach is a method to compare the amount of cDNA between 
different samples. It is a semi quantitative method, because only the relative change between 
the samples and not the absolute values are compared. SYBR Green binds specific to 
double stranded DNA. After binding to double stranded DNA the resulting complex emits 
green light, which can be measured and quantified. The amount of double stranded DNA 
duplicates after each cycle, thus the green light emission. The cycle threshold (ct) is 
determined manually after the run. It describes the number of cycles needed to exceed from 
the background at the start of the exponential phase of the curve. The cycle number is 
important to quantify the relative amount of cDNA between the samples. The higher the 
amount of cDNA in the sample the lower the ct value and vice versa.  
In order to calculate the relative fold change the delta-delta ct method was applied. 
Therefore, the difference between ct values of stimulated and non- stimulated endothelial 
cells or between db/db and wt mice was calculated and defined as Δct. In the next step the 
difference between ct values of the housekeeping gene RPL of the respective samples was 
calculated and defined as Δct housekeeping gene. The comparison with a housekeeping 
gene was necessary, because it excluded the possibility that a different amount cDNA was 
utilized at the beginning of the PCR. In order to compare Δct values with Δct housekeeping 
gene values the formula 2-ΔΔct was applied.  
The relative occurrence of mRNA of leptin receptor splicing variant ObRb, ObRa and ObRc 
was compared between CI-muMECs and glomerular endothelial cells as well as between 
whole kidneys from wt and db/db mice. TGF-β1 mRNA was compared between leptin-
stimulated and non-stimulated CI-muMECs. Therefore 50 ng cDNA were mixed with 2x 
SYBR green, forward and reverse primer (Table 2.) as duplicates and measured with a 
thermocycler with the following settings (Table 3.)  
                      
 
               35x 
 
 
duration temperature 
15 min 95°C 
20 sec 95°C 
30 sec 50°C 
20 sec 72°C 
Table 2: qRT-PCR program to multiply cDNA of leptin receptor splice variants  
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                35x 
 
Primer Sequence (5´to 3´) Final concentration 
RPL forward GGGAGCAACAAGAAAACCAA 1 pmol/µl 
RPL reverse ATTGTGGACCAGGAACTTGC 1 pmol/µl 
ObRb forward  TAACAGTGCTAACTTCTC 1 pmol/µl 
ObRb reverse TGACAGGACTATGGATAA 1 pmol/µl 
ObRa forward  GCACAAGGACTGAATTTC 1 pmol/µl 
ObRa reverse GAGAACATGAACACAACAA 1 pmol/µl 
ObRc forward  TTGTTTTGGGACGATGTT 1 pmol/µl 
ObRc reverse CAAAGAGTGTCCGTTCTC 1 pmol/µl 
TGF-β1 forward CGCCATCTATGAGAAAACC 1 pmol/µl 
TGF-β1 reverse GTAACGCCAGGAATTGT 1 pmol/µl 
Table 4: Primer used for qRT-PCR 
 
5.14 Agarose gel electrophoresis 
Agarose gel electrophoresis is a method to separate DNA and RNA fragments in a matrix of 
agarose. PCR products were separated by length in a 2 % agarose gel for 1 hour at 120 V in 
0.5 TBE. 3 - 4 µl ethidium bromide were added to the gel before it started to change from a 
liquid state to a solid state. 4 µl low range marker were loaded onto the gel as a reference. 
The gel was scanned after the run and analyzed qualitatively.  
 
5.15 Periodic acid-Schiff (PAS) staining 
Periodic acid-Schiff (PAS) is a staining method to detect glycoproteins in tissues. The 
reaction of periodic acid exclusively oxidizes the vicinal diols in these sugars resulting in the 
formation of aldehydes, which then react with the Schiff reagent. The reaction turns the 
respective regions into a purple-magenta color. Diabetic nephropathy is characterized inter 
alia by the expansion of the extracellular matrix. The PAS-reaction was therefore 
implemented to show differences in the size of the mentioned extracellular matrix, where 
glycoproteins found to be highly abundant.  Thus, the intensity of the color as well as the size 
of the stained area can be used as a marker for the degree of kidney damage.  
duration temperature 
15 min 95°C 
15 sec 95°C 
25 sec 60°C 
20 sec 72°C 
Table 3: qRT-PCR program to multiply RPL cDNA  
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First kidney slices of 5 µm were cut with a cryostat from frozen tissue embedded in tissue tek 
and dried on air for 4 - 7 days. After kidney slices were washed with millipore water they 
were incubated with 0.5 % PAS solution for 5 min. After the PAS-reaction the kidney slices 
were washed for 3 min in running water at the sink followed by a washing step with millipore 
water. By adding Schiff's reagent for 15 min the aldehydes react with the reagent and change 
their color to purple-magenta. The slices were washed with millipore water before the nuclei 
were counterstained for 2 min with hematoxylin. The slices were washed again for 3 min in 
running water at the sink before dehydration of the tissue started with an increasing alcohol-
series. At the end slices were covered with Eukitt and a cover slip and analyzed.  
 
5.16 Immunohistochemistry  
Immunohistochemistry is a popular application of immunostaining. Therefore, tissue slices 
are incubated with antibodies against a specific antigen. After removing excess antibodies, 
the tissue is incubated with a secondary antibody coupled to a fluorophore which detects the 
epitope of the first antibody. Thus, it will bind only to first antibodies, which are already bound 
to the antigen of interest.  
In order to quantify GPx-4 protein abundance in kidney slices of db/db mice, fpn+/- mice  and 
db/db/fpn+/- mice , as well as their respective controls, kidneys were cryoconserved in Tissue-
Tek, cut into 5 µm slices with a cryostat and frozen at -80 degrees Celsius until they were 
utilized. On the first day of immunostaining cryosections were thawed for 10 min at room 
temperature. Kidney slides were than fixated with 4 % PFA for 20 min at room temperature 
washed 3 times with PBS and had been permeabilized for 5 min with 0.3 % Triton-X-100 in 
PBS. Slides were washed again 3 times with PBS and were blocked with blocking solution 
(50 mM Tris-HCL, pH 7.4, 0.1 % BSA, 0.25 % casein and 15 mM sodiumacide) for 1 hour at 
room temperature. Subsequently slides were incubated in a wet chamber over night at 4 
degrees Celsius with the first antibodies anti-GPx-4 and anti-synaptopodin diluted in blocking 
solution as mentioned above. On the next day slides were washed 3 times with PBS and 
incubated with the secondary antibody for 1 hour at room temperature diluted in blocking 
solution as mentioned above. The slides were washed again 3 times and stained with DAPI 
for 8 min in order to visualize the nuclei. After the last two washing steps (with PBS) slides 
were embedded in mowiol, covered with a cover slip and dried over night at 4 degrees 
Celsius. On the next day marker expression was visualized by using the fluorescence 
microscope (Xellence (rt) - Olympus.  
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5.17 GPx-4 activity assay 
GPx-4 specific activity was measured in cell lysates of TGF-β1 and iron stimulated podocytes 
or of RSL-3 stimulated podocytes cultured in high glucose medium by our cooperation 
partner Fulvio Ursini (Universitiy of Padova, Department of Molecular medicine) using the 
GPx-4 specific substrate soybean PC as published (Ursini, Maiorino et al. 1985). 
 
5.18 Iron staining 
Kidney slices were stained by our cooperation partner Dr. Altamura (University Hospital 
Heidelberg, Department of Pediatric Hematology, Oncology and Immunology) using DAB 
advanced Pearls staining. Therefore, kidney slices of 3 µm on polylysine slides were treated 
for 20 min with Prussian blue followed by a 20 min incubation of DAB after tissue has been 
fixed for 24 hours in 10 % neutral buffer formalin, dehydrated and paraffin embedded. In 
addition, slices were counterstained with Meyer´s hematoxylin (Altamura, Kopf et al. 2017).  
 
5.19 Image analysis 
The light emission of the excited secondary antibodies was analyzed with the open source 
program QuPath. In order to find the region of interest the outer edge of the glomerulus 
defined by synaptopodin positive cells were encircled with the polygon selection tool. 
Subsequently, the mean of a region of interest was evaluated and devided by the size of the  
respective area. 
 
5.20 Statistics 
The program GraphPad Prism was utilized for statistical analysis. Parametric unpaired 
student’s t-test was used for two-group comparisons and one sample t-test for values 
expressed as relative to a control sample. For data encompassing three groups or more, 
one-way ANOVA with Tukey’s multiple comparisons test was employed. The results are 
shown as means ± SD. P-values < 0.05 were considered statistically significant. 
  
53 
 
6. Results 
6.1 Validation of the expression of cell-specific markers using 
immunofluorescence microscopy 
 
First, the type of cell lines used for the in vitro experiments as well as their purity was 
validated by immunofluorescence analysis.  
To this end, E11 podocytes were differentiated as described in MM 5.4.2. Differentiated E11 
podocytes express the podocyte-specific marker synaptopodin (Shankland, Pippin et al. 
2007). As shown (Figure 12), the E11 podocytes used for the following experiments were 
fully differentiated without any other contaminating cell species. 
      
Figure 12:  Validation of the expression of the podocyte specific marker synaptopodin in E11 
podocytes. Exemplary pictures showing differentiated E11 podocytes. E11 podocytes were 
proliferated at 33°C with 50 U/mL Interferon-γ (IFN-γ). After 14 days of differentiation at 37°C without 
IFN-γ podocytes express the podocyte-specific marker synaptopodin. The expression of synaptopodin 
was visualized by immunofluorescence analysis.  
The identity and the purity of the pulmonary microvascular endothelial cell line CI-muMECS 
were confirmed by a positive CD31 immunofluorescence staining (Figure 13).  
      
Figure 13:  Validation of the expression of the endothelial cell specific marker CD31 in CI-
muMECs. Exemplary pictures showing a confluent monolayer of CI-muMECs. CI-muMECS express 
the endothelial cell specific marker CD31. The expression of the membrane bound CD31 was 
visualized by immunofluorescence analysis.  
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Primary podocytes used for the in vitro experiments as well as their purity were validated by 
positive synaptopodin immunofluorescene (Figure 14). To this end, outgrowing cells from 
isolated glomeruli as described in MM 5.4.2 were stained after 4-week cultivation.  
       
Figure 14: Validation of expression of the podocyte specific marker synaptopodin in primary 
podocytes. Exemplary pictures showing primary podocytes isolated from wildtype mice and express 
the podocyte specific marker synaptopodin. The expression of synaptopodin was visualized by 
immunofluorescene stainings. 
Primary mouse glomerular endothelial cells (PeloBiotech) were stained. As shown in Figure 
15, the primary mouse glomerular endothelial cells used for the following experiments were 
endothelial cells based on their morphology and the respective staining (Rops, van der Vlag 
et al. 2004).  
      
Figure 15:  Validation of the expression of the endothelial cell specific marker CD31 in primary 
mouse glomerular endothelial cells. Exemplary pictures showing primary mouse glomerular 
endothelial cells (PeloBiotech) expressing the endothelial cell specific marker CD31. The expression 
of CD31 was visualized by immunofluorescence stainings.  
 
6.2 Detection of leptin receptor splice variants by realtime PCR 
 
As a next step the long leptin receptor splice variant 1 (ObRb), the short variant 2 (ObRa) 
and variant 3 (ObRc) were compared qualitatively and quantitatively between CI-muMECs 
and primary glomerular endothelial cells or within the respective cell species using realtime 
PCR.  
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First, the different leptin receptor splicing variant transcripts were compared within the cell 
species. In CI-muMECs the amount of transcript ObRa is 3.3-fold increased compared to  
 
Figure 16:  Quantification of the amount of leptin receptor splice variants ObRb, ObRa and 
ObRc transcripts in CI-muMECs and in gECs. Exemplary graph showing the amount of ObRa and 
ObRc mRNA in CI-muMECs and gECs compared to the long leptin receptor splicing variant ObRb in 
the respective cell type. The values were obtained by real time PCR from 3 replicates by using the 
∆∆ct method.  
 
Figure 17:  Quantification of the amount of leptin receptor splice variants ObRb, ObRa and 
ObRc transcripts between gECs and CI-muMECs. Exemplary graph showing the amount of ObRb, 
ObRa and ObRc mRNA in gECs compared to the respective amount of ObRb, ObRa and ObRc 
mRNA in CI-muMECs. The values were obtained by real time PCR from 3 replicates by using the ∆∆ct 
method.   
transcript ObRb. Moreover, transcript ObRc is 11.6-fold more abundant compared to 
transcript ObRb (Figure 16).  
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A comparison of the respective leptin receptor splice variant transcripts between CI-
muMECS and primary glomerular endothelial cells showed that the amount of the transcript 
of the long leptin receptor splice variant ObRb is more than 13-fold higher in primary 
glomerular endothelial cells compared to the CI-muMECs (Figure 17). The amount of the 
short leptin receptor splice variant transcript ObRa is more than 5.5-fold increased in primary 
glomerular endothelial cells compared to the CI-muMECs, whereas the amount of the short 
leptin receptor splice variant transcript ObRc was neclegtably low (0.048). 
 
6.3 Cell culture 
6.3.1 Endothelial cells 
6.3.1.1 TGF-β1 mRNA expression in leptin-stimulated CI-muMECs 
 
In order to elucidate the effects of leptin on TGF-β1 mRNA expression CI-muMECs were 
stimulated for 24 hours with 10 and 100 ng/mL murine recombinant leptin. There was no 
increase in TGF-β1 mRNA expression in leptin-stimulated compared to the non-stimulated 
control cells detectable (Figure 18).  
 
Figure 18:  Effect of leptin on TGF-β1 mRNA levels in CI-muMECs. CI-muMECs were stimulated 
for 24 hours with 10 and 100 ng/mL murine recombinant leptin. Messenger RNA levels were 
compared between the groups and shown as a relative fold change in percent of control. The results 
are shown as means ± SD with n=3 per group.  
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6.3.1.2 Active TGF-β1 in the medium of leptin-stimulated CI-muMECS 
 
As there was no difference detectable at the transcriptional level, it was likely that TGF-β1 
was processed post translationally. As mentioned above the non-active latent TGF-β1 needs 
to be released from the extracellular matrix and cleaved by metalloproteases in order to be 
activated. Activated TGF-β1 was detected in medium supernatants of CI-muMECs stimulated 
with 10 or 100 ng/mL leptin using an appropriate ELISA. The active TGF-β1 concentration 
was significantly increased in CI-muMECS stimulated with 10 ng/mL leptin (1.36-fold) or 100 
ng/mL leptin (1.66-fold) as compared to non-stimulated control cells (Figure 19). 
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Figure 19: Effect of leptin on TGF-β1 release/activation in CI-muMECs. CI-muMECs were 
stimulated for 24 hours with 10 and 100 ng/mL murine recombinant leptin. Active TGF-β1 
concentrations were compared between the groups and are shown as a relative fold change in 
percent of the unstimulated control.  The results are shown as means ± SD with n=5-6 per group. 
*p<0.05 as indicated   
 
6.3.1.3 Active TGF-β1 in the medium of leptin-stimulated primary glomerular 
endothelial cells 
 
Primary mouse glomerular endothelial cells purchased from PeloBiotech were stimulated the 
same way as the CI-muMECs for 24 hours with 10 and 100 ng/mL murine recombinant 
leptin. No effect on TGF-β1 mRNA expression in leptin-stimulated compared to the non-
stimulated control cells was observed. The active TGF-β1 concentration was not changed in 
primary glomerular endothelial cells stimulated with 10 ng/mL leptin and significantly 
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increased (1.24-fold) in primary glomerular endothelial cells stimulated with 100 ng/mL leptin 
compared to the control group (Figure 20). When compared to the CI-muMECs, the 
magnitude of the effect of leptin on TGF-β1 release seemed less pronounced, which was due 
to the fact that baseline release of TGF-β1 from these cells was significantly higher than from 
the CI-muMECs (not shown). 
 
Figure 20: Effect of leptin on TGF-β1 release in primary murine glomerular endothelial cells. 
Primary murine glomerular endothelial cells (PeloBiotech) were stimulated for 24 hours with 10 and 
100 ng/mL murine recombinant leptin. Active TGF-β1 concentrations were compared between the 
groups and are shown as a relative fold change in percent of the unstimulated control.  The results are 
shown as means ± SD with n=3 per group. *p<0.05 as indicated   
 
6.3.2 Podocytes 
6.3.2.1 GPx-1 protein abundance in leptin-stimulated or TGF-β1-stimulated E11 
podocytes  
 
Next E11 podocytes were stimulated for 5 days with different concentrations (5-200 ng/mL) 
of murine recombinant leptin or different concentrations of murine recombinant TGF-β1 (2-50 
ng/mL) to investigate whether it affects the abundance of GPx-1 protein or not. Neither E11 
podocytes stimulated with low concentrations of leptin (5 and 15 ng/mL) nor E11 podocytes 
stimulated with high concentrations of leptin (50, 100 or 200 ng/mL) responded to the 
respective stimulus with a change in their GPx-1 protein content (Figure 21 a). Moreover, 
there was no change in the amount of GPx-1 protein detectable in the TGF-β1-stimulated 
E11 podocytes independent of the dose used for stimulating the cells (Figure 21 b).  
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Figure 21: Effect of leptin-stimulated or TGF-β1-stimulated E11 podocytes on GPx-1 protein 
abundance. GPx-1 protein abundance was determined in E11 podocytes stimulated with different 
concentrations (5-200 ng/mL) of murine recombinant leptin (a) or different concentrations (2-50 ng/mL) 
of murine recombinant TGF-β1 (b). The amount of protein per sample was normalized with β-actin.  
GPx-1 protein abundance was compared between groups and shown as a relative fold change in 
percent of their respective control. The results are shown as means ± SD with n=3 per group. *p<0.05 
as indicated   
 
6.3.2.2 GPx-4 protein abundance in leptin-stimulated or TGF-β1-stimulated E11 
podocytes  
 
E11 podocytes were stimulated for 5 days with different concentrations (5-200 ng/mL) of 
murine recombinant leptin or different concentrations of murine recombinant TGF-β1 (2-50 
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ng/mL). Neither E11 podocytes stimulated with low concentrations of leptin (5 and 15 ng/mL) 
nor E11 podocytes stimulated with high concentrations of leptin (50, 100 or 200 ng/mL) 
responded to the respective stimulus with a change in their GPx-4 protein content (Figure 22 
a). In contrast, GPx-4 protein abundance was 24 % lower in E11 podocytes stimulated with 2  
 
Figure 22:  Effect of leptin-stimulated or TGF-β1-stimulated E11 podocytes on GPx-4 protein 
abundance in a dose-dependent manner. GPx-4 protein abundance was determined in E11 
podocytes stimulated with different concentrations (5-200 ng/mL) of murine recombinant leptin (a) or 
different concentrations (2-50 ng/mL) of murine recombinant TGF-β1 (b). The amount of protein per 
sample was normalized with β-actin. GPx-1 protein abundance was compared between groups and 
shown as a relative fold change in percent of their respective control. The results are shown as means 
± SD with n=3 per group. *p<0.05 as indicated   
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ng/mL TGF-β1and already significantly reduced (35 %) in cells stimulated with 4 ng/mL TGF-
β1. This decline in GPx-4 protein abundance was augmented in a concentration-dependent 
manner (Figure 22 b). 
E11 podocytes were stimulated for 5 days with 30 ng/mL murine recombinant TGF-β1. As 
shown (Figure 19) this concentration equals the concentration of released/activated TGF-β1 
measured by ELISA of the leptin-stimulated CI-muMECs. E11 podocytes were harvested 
every 24 hours to visualize the kinetic properties of the GPx-4 protein decline. After 24 hours 
GPx-4 protein abundance was reduced by 27 %, and this inhibitory effect reached 
significance at 48 hours of TGF-β1-stimulation (Figure 23). 
 
Figure 23: Effect of TGF-β1-stimulated E11 podocytes on GPx-4 protein abundance in a time-
dependent manner. GPx-4 protein abundance was determined in E11 podocytes stimulated with 30 
ng/mL of murine recombinant TGF-β1. The amount of protein per sample was normalized with β-actin. 
GPx-1 protein abundance was compared between groups and shown as a relative fold change in 
percent of their respective control. The results are shown as means ± SD with n=3-4 per group. 
*p<0.05 as indicated   
To compare possible differences in the kinetic properties of the amount of GPx-4 protein in 
E11 podocytes and primary podocytes, primary podocytes were cultivated the same way as 
E11 podocytes, and then stimulated for 5 days with 30 ng/mL murine recombinant TGF-β1. 
Moreover, they were harvested every 24 hours to visualize the kinetic properties of the 
presumed inhibitory effect on GPx-4 protein abundancve. Surprisingly the primary podocytes 
responded to TGF-β1 stimulation with a temporal but not significant increase rather than 
decrease in GPx-4 protein abundance (Figure 24). 
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Figure 24: Effect of TGF-β1-stimulated primary podocytes on GPx-4 protein abundance in a 
time-dependent manner. GPx-4 protein abundance was determined in primary podocytes stimulated 
with 30 ng/mL of murine recombinant TGF-β1. The amount of protein per sample was not normalized 
with β-actin. GPx-1 protein abundance was compared between groups and shown as a relative fold 
change in percent of their respective control. The results are shown as means ± SD with n=3 per 
group. *p<0.05 as indicated   
 
6.3.2.2 GPx-4 protein abundance in E11 podocytes exposed to TGF-β1 and/or 
iron overload 
 
We further investigated whether iron imported into the cell via the transferrin receptor has an 
additional effect on GPx-4 protein content of E11 podocytes. Accordingly, E11 podocytes 
were stimulated for 5 days with 30 ng/mL murine recombinant TGF-β1, 30 µM transferrin 
(apotransferrin or holotransferrin) as an iron donor or with a combination of both. 
Apotransferrin is the non-loaded transferrin form and should be loaded with iron from the iron 
pool available in the medium. Apotransferrin-stimulated E11 podocytes revealed a small but 
insignificant rise in GPx-4 protein, whereas this was significantly reduced by 51 % in TGF-β1-
stimulated E11 podocytes (Figure 25a). The combination of apotransferrin and TGF-β1 had 
no additional effect on GPx-4 protein abundance in the E11 podocytes.  
Holotransferrin is the iron-loaded form of transferrin. After releasing iron into the cell via 
endocytosis, empty transferrin shuttles back and is reloaded with new iron from the labile iron 
pool in the medium. Holotransferrin alone had no effect on GPx-4 protein content, whereas 
this was significantly reduced by 52 % in TGF-β1-stimulated E11 podocytes (Figure 25b). 
Combination of holotransferrin and TGF-β1 again had no additional inhibitory effect on GPx-4 
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protein abundance was significantly. Thus, neither the unloaded nor the iron-loaded form of 
transferrin had a measurable impact on GPx-4 protein abundance in the E11 podocytes.  
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Figure 25:  Impact of iron overload with or without concomitant TGF-β1 exposure on GPx-4 
protein abundance in E11 podocytes. GPx-4 protein abundance was measured in E11 podocytes 
stimulated with 30 ng/mL murine recombinant TGF-β1, 30 µM transferrin [apotransferrin (At, a) or 
holotransferrin (Ht, b)] or with a combination of both for 5 days. The amount of protein per sample was 
normalized with β-actin. Unstimulated cells served as control and were set to 100 %. Changes in GPx-
4 protein abundance were calculated in percent of the corresponding control value. Means ± SD of 
n=4 per group are shown. *p<0.05 as indicated 
To verify whether a non-transferrin receptor-mediated iron transport plays a role in this 
context, we also investigated the potential role of an increased labile iron pool and 
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investigated alternative iron uptake pathways. To this end, E11 podocytes were stimulated 
for 5 days with 30 ng/mL murine recombinant TGF-β1, 30 µM FeNTA as an iron donor or 
with a combination of both. FeNTA itself had no effect on GPx-4 protein content, but this was 
significantly reduced (45 %) in TGF-β1-stimulated E11 podocytes (Figure 26). The 
combination of FeNTA and TGF-β1 did not surpass the inhibitory effect of TGF-β1 alone.  
 
Figure 26:  Impact of iron overload with or without concomitant TGF-β1 exposure on GPx-4 
protein abundance in E11 podocytes. GPx-4 protein abundance was measured in E11 podocytes 
stimulated with 30 ng/mL murine recombinant TGF-β1, 30 µM FeNTA or with a combination of both for 
5 days. The amount of protein per sample was normalized with β-actin. Unstimulated cells served as 
control and were set to 100 %. Changes in GPx-4 protein abundance were calculated in percent of the 
corresponding control value. Means ± SD of n=4 per group are shown. *p<0.05 as indicated 
 
6.3.2.3 GPx-4 protein abundance in E11 podocytes stimulated with TGF-β1 and 
iron in high-glucose medium 
 
GPx-4 protein abundance was significantly reduced in TGF-β1-treated E11 podocytes, 
whereas iron overload caused no additional reduction in the amount of GPx-4 protein.  In 
order to activate the proposed feedback loop an additional trigger such as hyperglycemia 
could be required. Accordingly, E11 were cultured either in low-glucose or in high-glucose 
medium and part of the experiments described above repeated under these conditions. High-
glucose medium itself had no effect on GPx-4 protein content while TGF-β1 still exerted its 
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inhibitory effect (Figure 27). Holotransferrin again did not add to the inhibitory effect of TGF-
β1 in E11 podocytes cultured in high-glucose medium. 
 
Figure 27:  Impact of high glucose levels in iron- and TGF-β1-stimulated E11 podocytes on 
GPx-4 protein abundance. GPx-4 protein abundance was measured in E11 podocytes cultured in 
low glucose medium (5 mM) or high glucose medium (30 mM) and stimulated with 30 ng/mL of murine 
recombinant TGF-β1 or co-stimulated with 30 ng/mL of murine recombinant TGF-β1 and 30 µM 
holotransferrin in high glucose medium. The amount of protein per sample was normalized with β-
actin. Unstimulated cells served as control and were set to 100 %. Changes in GPx-4 protein 
abundance were calculated in percent of the corresponding control value. Means ± SD of n=3 per 
group are shown. *p<0.05 as indicated 
 
6.3.2.4 GPx-4 activity in E11 podocytes exposed to TGF-β1 and/or iron in high-
glucose medium 
 
As there was no difference on the GPx-4 protein level detectable, GPx-4 specific activity was 
measured in E11 podocytes stimulated for 3 days with 30 ng/mL murine recombinant TGF-β1 
and 30 µM holotransferrin in high glucose medium (30 mM).  
In order to verify the efficiency of the GPx-4 inhibitor RSL-3, RSL-3 (10 µM) was added as a 
control. Since RSL-3 was reconstituted in DMSO, a DMSO control was included as well. The 
activity of GPx-4 was significantly reduced by 29% in E11 podocytes co-incubated with TGF-
β1 and holotransferrin for 3 days in high-glucose medium (Figure 28). Moreover, the activity 
of GPx-4 was reduced to zero in the presence of RSL-3, confirming the specificity of the 
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GPx-4 activity assay. The GPx-4 activity was not further inhibited in E11 podocytes co-
stimulated with TGF-β1 and holotransferrin for 3 days in high glucose medium compared to 
the amount of GPx-4 protein (Figure 28). In addition, there was no compensatory 
upregulation of the GPx-4 activity compared to the non-stimulated controls. The decrease in 
activity reflects almost the decrease in the amount of GPx-4 protein measured after 3 days. 
  
Figure 28:  Impact of high glucose levels in iron- and TGF-β1-stimulated E11 podocytes on 
GPx-4 activity. GPx-4 activity was measured in E11 podocytes co-stimulated with murine 
recombinant TGF-β1 (30 ng/mL) and 30 µM holotransferrin or with 10 µM RSL-3 as an additional 
control stimulus in high glucose medium (30 mM). Changes in GPx-4 activity were calculated in 
percent of the corresponding control value. Means ± SD of n=3 per group are shown. *p<0.05 as 
indicated 
 
6.3.3 Co-culture of endothelial cells and podocytes 
6.3.3.1 GPx-4 expression in E11 podocytes co-cultured with CI-muMECs 
 
In more than two separate experiments we showed that endothelial cells respond to leptin 
with a significant increase in the release/activation of TGF-β1, and that podocytes respond to 
TGF-β1 with a significant decrease in GPx-4 protein abundance. Next, E11 podocytes and 
CI-muMECs were co-cultured in a set up mimicking the filtration barrier of the kidney. Thus, 
CI-muMECs were cultured as a monolayer on transwell inserts consisting of a filter with a 
pore size of 0.4 µm, whereas E11 podocytes were cultured as a monolayer on the bottom of 
the respective wells and stimulated with 100 ng/mL murine recombinant leptin for 5 days.  
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Figure 29: Effect of leptin-stimulated CI-muMECs co-cultured with E11 podocytes on GPx-4 
protein abundance in E11 podocytes. GPx-4 protein abundance was determined in E11 podocytes 
stimulated with 30 ng/mL of murine recombinant TGF-β1 or 100 ng/mL of murine recombinant leptin, 
in E11 podocytes co-cultured with CI-muMECs and in E11 podocytes co-cultured with leptin-
stimulated CI-muMECs. The amount of protein per sample was normalized with β-actin. Unstimulated 
cells served as control and were set to 100 %. Changes in GPx-4 protein abundance were calculated 
in percent of the corresponding control value. Means ± SD of n=4-5 per group are shown. *p<0.05 as 
indicated.  
E11 podocytes without co-cultured CI-muMECs were stimulated with 30 ng/mL murine 
recombinant TGF-β1 or with 100 ng/mL murine recombinant leptin as a control stimulus. 
GPx-4 was significantly reduced by 47% in TGF-β1-treated E11 podocytes compared to the 
untreated control (Figure 29). There was no significant difference between E11 podocytes 
exposed to leptin and the non-stimulated controls. GPx-4 protein abundance was 24% lower 
in E11 podocytes co-cultured with CI-muMECs. GPx-4 protein abundance was reduced by a 
further 22% in E11 podocytes co-cultured with leptin-stimulated CI-muMECs. 
In order to emphasize the impact of the potential paracrine TGF-β1 signaling between leptin-
stimulated CI-muMECs co-cultured with E11 podocytes and the resulting decrease in GPx-4 
protein abundance in E11 podocytes, GPx-4 protein abundance was compared between 
leptin-stimulated CI-muMECs co-cultured with E11 podocytes and non-stimulated co-cultured 
E11 podocytes. GPx-4 protein abundance was significantly reduced by 22% in E11 
podocytes co-cultured with leptin-stimulated CI-muMECs as compared to E11 podocytes co-
cultured with non-stimulated CI-muMECs (Figure 30).  
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Figure 30: Effect of leptin-stimulated CI-muMECs co-cultured with E11 podocytes on GPx-4 
protein abundance in E11 podocytes. GPx-4 protein abundance was determined in E11 podocytes 
co-cultured with CI-muMECs and in E11 podocytes co-cultured with leptin-stimulated CI-muMECs. 
The amount of protein per sample was normalized with β-actin. Unstimulated cells served as control 
and were set to 100 %. Changes in GPx-4 protein abundance were calculated in percent of the 
corresponding control value. Means ± SD of n=5 per group are shown. *p<0.05 as indicated 
 
6.3.3.2 GPx-4 expression in E11 podocytes co-cultured with gECs 
 
Even though CI-muMECs are microvascular endothelial cells they have been isolated from 
the lung. As already discussed, gECs were used for further experiments as they have been 
isolated from the kidney and were not immortalized. According to the manufacturer these 
cells keep their primary cell character in low passage numbers. Thus, gECs were cultured as 
a monolayer on transwell inserts consisting of a filter with a pore size of 0.4 µm, whereas 
E11 podocytes were cultured as a monolayer on the bottom of the respective wells and 
stimulated with 100 ng/mL murine recombinant leptin with or without 10 µg/mL pan/TGF-β 
antibody or with 100 ng/mL murine recombinant leptin and 10 µg/mL TGF-β I and II receptor 
blocker for 5 days. The TGF-β I and II receptor blocker was reconstituted in DMSO, therefore 
a DMSO control was included.  
GPx-4 was about 10 % reduced in E11 podocytes co-cultured with leptin-stimulated gECs 
compared to the unstimulated co-cultured cells (Figure 31). There was no significant 
difference in the amount of GPx-4 protein in E11 podocytes co-cultured with leptin-stimulated 
gECs when the neutralizing TGF-β1,2,3 antibody or the TGF-β I and II receptor blocker was 
added. As the amount of GPx-4 protein was only reduced around 10 %, it was difficult to 
block this effect on a significant level. 
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Figure 31: Impact of leptin-stimulated gECs co-cultured with E11 podocytes on GPx-4 protein 
abundance in E11 podocytes. GPx-4 protein abundance was determined E11 podocytes co-cultured 
with gECs and in E11 podocytes co-cultured with leptin-stimulated CI-muMECs or with 100 ng/mL 
murine recombinant leptin and 10 µg/mL TGF-β1,2,3 antibody (TGF-β ab) or with 100 ng/mL murine 
recombinant leptin and 10 µg/mL TGF-β I and II receptor blocker (TGF-β rb) for 5 days. A DMSO 
control was included. The amount of protein per sample was normalized with β-actin. Unstimulated 
cells served as control and were set to 100 %. Changes in GPx-4 protein abundance were calculated 
in percent of the corresponding control value. Means ± SD of n=3-6 per group are shown.  
 
6.3.3.3 GPx-4 expression in primary podocytes co-cultured with gECs 
 
E11 podocytes are immortalized podocytes, which may have lost or gained characteristic 
features during their cultivation. To exclude that the potential paracrine TGF-β1 signaling 
between endothelial cells and podocytes is not only an artefact of the cell culture, primary 
podocytes were used for the next experiment. The same set up as employed for the cell lines 
was utilized. Primary podocytes without co-cultured gECs were stimulated with 30 ng/mL 
murine recombinant TGF-β1 or with 100 ng/mL murine recombinant leptin as a control 
stimulus. The amount of GPx-4 protein was not changed in TGF-β1 or leptin-stimulated 
primary podocytes compared to the non-stimulated control (Figure 32). Moreover, the 
amount of GPx-4 protein was not changed in primary podocytes co-cultured with leptin-
stimulated gECs compared to the primary podocytes co-cultured with non-stimulated gECs. 
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Figure 32: Effect of leptin-stimulated gECs co-cultured with primary podocytes on GPx-4 
protein abundance in primary podocytes. GPx-4 protein abundance was determined in primary 
podocytes stimulated with 30 ng/mL of murine recombinant TGF-β1 or 100 ng/mL of murine 
recombinant leptin, in primary podocytes co-cultured with gECs and in primary podocytes co-cultured 
with leptin-stimulated gECs. The amount of protein per sample was normalized with β-actin. 
Unstimulated cells served as control and were set to 100 %. Changes in GPx-4 protein abundance 
were calculated in percent of the corresponding control value. Means ± SD of n=3 per group are 
shown. 
 
Figure 33: Effect of leptin-stimulated gECs co-cultured with primary podocytes on GPx-4 
protein abundance in primary podocytes. GPx-4 protein abundance was determined in primary 
podocytes co-cultured with gECs and in primary podocytes co-cultured with leptin-stimulated gECs. 
The amount of protein per sample was normalized with β-actin. Unstimulated cells served as control 
and were set to 100 %. Changes in GPx-4 protein abundance were calculated in percent of the 
corresponding control value. Means ± SD of n=3 per group are shown. 
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To emphasize the potential paracrine TGF-β1 signaling between leptin-stimulated gECs co-
cultured with primary podocytes and the resulting decrease in GPx-4 protein abundance in 
E11 podocytes, GPx-4 protein abundance was compared between leptin-stimulated gECs 
co-cultured with primary podocytes and non-stimulated co-cultured primary podocytes. GPx-
4 protein abundance was almost significantly reduced by 60 % in primary podocytes co-
cultured with leptin-stimulated gECs when compared to the primary podocytes co-cultured 
with non-stimulated gECs (Figure 33).  
 
6.4 Leptin receptor-deficient mice lacking the long leptin receptor splicing 
variant (Ob-Rb) 
 
Leptin receptor-deficient mice (B6.BKS(D)-Leprdb/J) from Jackson Laboratory (Stock number 
000697) are characterized by an insert of 106 bp in the long leptin receptor splice variant Ob-
Rb (Chen, Charlat et al. 1996, Lee, Proenca et al. 1996). This insert has the same base pair 
sequence as the short leptin receptor splice variant Ob-Ra, which consists of a premature 
stop codon (Figure 34) (Chen, Charlat et al. 1996, Lee, Proenca et al. 1996). Thus, in db/db 
mice truncated leptin receptor transcript 1 (Ob-Rb) and leptin receptor 3 (Ob-Ra) are both 
translated into leptin receptor Ob-Ra (Chen, Charlat et al. 1996).  
 
Figure 34: Exemplary image of an agarose gel showing PCR products of leptin receptor 1 (Ob-
Rb) in wild-type and db/db mice (primer sequence according to Hermann Kalwa et al. Cellular 
Physiology (2014). 
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6.5 Ex vivo data 
6.5.1 Extracelluar matrix expansion in the glomeruli of 32-42 weeks old fpn+/- 
and db/db mice 
 
Diabetic nephropathy is characterized by an expansion of the mesangium, which consists of 
mesangial cells and extracellular matrix. Glycoproteins of the extracellular matrix as well as 
glycoproteins on the surface of cell membranes can be visualized with a PAS (periodic acid 
Schiff) reaction. Thus, cryosections of kidneys from 24 and from 32-42 weeks old db/db 
mice, their heterozygous littermates, iron overload-simulating fpn+/- mice and db/db/fpn+/- 
mice were first incubated with Schiffs reagent and subsequently with hematoxylin as a 
counterstain. The amount of extracellular matrix and membranes shown as mean glomerular 
value in arbitrary units was not altered in heterozygous 24 weeks old db/db/fpn+/- mice as 
compared to db/db mice (Figure 35).  
 
Figure 35: Impact of leptin signaling and impaired iron homeostasis on mesangial expansion 
and membrane thickening in 24 weeks old male mice. Extracelllular matrix accumulation and 
membrane thickening was determined by the quantification of the PAS positive staining in 
cryosections of kidneys from 24 weeks old male db/db mice, their heterozygous littermates, fpn+/- mice 
and db/db/fpn+/- mice. The values obtained for the PAS staining were normalized with the area of the 
glomerulus and shown as a mean glomerular pixel value in arbitrary units with a standard deviation. 
Means ± SD of n=3-5 per group are shown. 
The amount of extracellular matrix and membranes of homozygous db/db mice was also not 
changed compared to their heterozygous littermates. There was also no change in the 
amount extracellular matrix and membranes of db/db/fpn+/- mice detectable. Thus, an 
impaired iron homeostasis (systemic iron overload) as well as impaired leptin signaling did 
not change the amount of extracellular matrix and membranes in 24 weeks old male mice. 
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In 32-42 weeks old male mice the amount of extracellular matrix and membranes shown as 
mean glomerular value in arbitrary units was increased by 41 % albeit not significantly in 
heterozygous 24 weeks old db/db/fpn+/- mice as compared to db/db mice (Figure 36). The 
amount of extracellular matrix and membranes of homozygous db/db mice was significantly 
increased by 28% as compared to their heterozygous littermates. There was no significant 
change in the amount of extracellular matrix and membranes of db/db/fpn+/- mice detectable 
compared to the db/db mice. Remarkably, the trends seen in the fpn+/- mice and the 
significant difference seen in the db/db homozygous mice seemed to be accumulated in 
db/db/fpn+/- mice compared to the control mice. The amount of extracellular matrix and 
membranes of db/db/fpn+/- mice was significantly increased by 72% as compared to the 
control mice. Both, an impaired iron homeostasis (systemic iron overload) as well as 
impaired leptin signaling seemed to have an impact of the amount of extracellular matrix and 
membranes in 32-42 weeks old male mice. 
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Figure 36: Impact of leptin signaling and impaired iron homeostasis on mesangial expansion 
and membrane thickening in 32-42 weeks old male mice. Extracellular matrix accumulation and 
membrane thickening was determined by the quantification of the PAS positive staining in 
cryosections of kidneys from 32-42 weeks old male db/db mice, their heterozygous littermates, fpn+/- 
mice and db/db/fpn+/- mice. The values obtained for the PAS staining were normalized with the area of 
the glomerulus. Means ± SD of n=7-8 per group are shown. *p<0.05 as indicated 
 
6.5.2 Iron accumulation in the glomeruli of 32-42 weeks old fpn +/- mice  
 
An impaired iron homeostasis (systemic iron overload) was associated with T2D in humans. 
As a consequence, epithelial cells in the liver had increased levels of stored iron. We 
hypothesized that epithelial cells in the kidney suffer as well from increased iron storage. 
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Therefore, iron in cryosections of kidneys from 24 weeks old and from 32-42 weeks old db/db 
mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice was stained. DAB 
advanced pearls staining was applied to visualize stored iron in the glomeruli of the 
respective mice. The amount of stored iron in the glomeruli shown as mean DAB intensity 
was not altered in 24 weeks old db/db mice, fpn+/- mice and db/db/fpn+/- mice compared to 
the control mice. Thus, an impaired iron homeostasis (systemic iron overload) as well as 
impaired leptin signaling did not change the amount stored iron in the glomeruli of 24 weeks 
old male mice. 
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Figure 37: Impact of leptin signaling and impaired iron homeostasis on iron accumulation in 
the glomeruli of 24 weeks old male mice. Iron accumulation in the glomeruli was determined by the 
quantification of the DAB advanced pearls staining in cryosections of kidneys from 24 weeks old male 
db/db mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice. The values obtained for 
the pearls staining were normalized with the area of the glomerulus. Means ± SD of n=3-5 per group 
are shown.  
In 32-42 weeks old male mice the amount of stored iron in the glomeruli shown as mean 
DAB intensity was significantly increased by 150 % in 24 weeks old fpn+/- mice and by 190 % 
in 24 weeks old db/db/fpn+/- mice compared to their homozygous littermates (Figure 38). 
Moreover, the amount of stored iron in the glomeruli of db/db mice was not altered compared 
to their heterozygous littermates. The iron accumulation seen in fpn+/- mice seemed to be 
enhanced in db/db/fpn+/- mice compared to the control mice. An impaired leptin signaling 
seemed to enhance the amount of stored iron in 32-42 weeks old male mice suffering from 
an impaired iron homeostasis (systemic iron overload).  
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Figure 38: Impact of leptin signaling and impaired iron homeostasis on iron accumulation in 
the glomeruli of 32-42 weeks old male mice. Iron accumulation in the glomeruli was determined by 
the quantification of the DAB advanced pearls staining in cryosections of kidneys from 32-42 weeks 
old male db/db mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice. The values 
obtained for the pearls staining were normalized with the area of the glomerulus. Means ± SD of n=3-5 
per group are shown. *p<0.05 as indicated  
 
6.5.3 GPx-4 protein reduction in the glomeruli of 32-42 weeks old db/db mice 
 
Reduced amounts of GPx-4 protein in the glomeruli are associated with T2D in humans. In 
order to test whether this observation is also true for our T2D mouse models, GPx-4 was 
stained in cryosections of kidneys from 24 weeks old and from 32-42 weeks old db/db mice, 
their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice.  
The amount of GPx-4 protein in the glomeruli shown as GPx-4 protein (in % of control) was 
not altered in heterozygous 24 weeks old Fpn mice compared to their homozygous 
littermates (Figure 39), whereas it was significantly increased by 35 % in homozygous db/db 
mice compared to their heterozygous littermates. In contrast, GPx-4 protein abundance was 
not altered db/db/fpn+/- mice compared to the control mice. Thus, a mildly impaired leptin 
signaling seemed to increase the amount of GPx-4 protein in the glomeruli of these mice. 
This beneficial effect was revised in the db/db/fpn+/- mice.  
The area of the synaptopodin stained glomeruli was slightly increased (p=0.05) in 24 weeks 
old fpn+/- mice and in db/db/fpn+/- mice compared to the control mice (Figure 40), whereas it 
was significantly increased by 32 % in db/db mice compared to fpn+/- mice. Thus, impaired 
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leptin signaling at the beginning of the disease seemed to increase the size of the glomeruli 
of 24 weeks old male mice. 
 
 
Figure 39: Impact of leptin signaling and impaired iron homeostasis on total GPx-4 protein 
abundance in the glomeruli of 24 weeks old male mice. Positive GPx-4 staining was quantified as 
mean intensities (as described in MM (section 5.1.9, page 52) from cryosections of kidneys from 24 
weeks old male db/db mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice. Means ± 
SD of n=3-7 per group are shown. *p<0.05 as indicated 
 
Figure 40: Impact of leptin signaling and impaired iron homeostasis on the size of the 
glomeruli of 24 weeks old male mice. The area of the synaptopodin stained glomeruli was 
determined in cryosections of kidneys from 24 weeks old male db/db mice, their heterozygous 
littermates, fpn+/- mice and db/db/fpn+/- mice. The values obtained were shown as area. Means ± SD of 
n=3-7 per group are shown. *p<0.05 as indicated 
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Figure 41: Impact of leptin signaling and impaired iron homeostasis on GPx-4 protein 
abundance in the glomeruli of 24 weeks old male mice. Positive GPx-4 staining was quantified as 
mean intensities (as described in MM (section 5.1.9, page 52) from cryosections of kidneys from 24 
weeks old male db/db mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice. The 
values obtained from the GPx-4 staining were normalized with the area of the synaptopodin stained 
glomerulus. Means shown as GPx-4 protein abundance/area ± SD of n=3-7 per group are shown.  
 
 
Figure 42: Impact of leptin signaling and impaired iron homeostasis on GPx-4 protein 
abundance in the glomeruli of 32-42 weeks old male mice. Positive GPx-4 staining was quantified 
as mean intensities (as described in MM (section 5.1.9, page 52) from cryosections of kidneys from 
32-42 weeks old male db/db mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice. 
Means ± SD of n=7-8 per group are shown. 
The amount of GPx-4 protein per area in the glomeruli was not altered in 24 weeks old fpn+/- 
mice compared to their homozygous littermates (Figure 41), in db/db mice compared to their 
heterozygous littermates and in db/db/fpn+/- mice compared to the control mice. Thus, an 
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impaired iron homeostasis (systemic iron overload) as well as impaired leptin signaling did 
not change the amount of GPx-4 protein abundance/area in the glomeruli of 24 weeks old 
male mice.  
The amount of GPx-4 protein in the glomeruli was not changed in heterozygous 32-42 weeks 
old fpn+/- mice compared to their homozygous littermates (Figure 42), as well as in db/db 
mice compared to their heterozygous littermates. In db/db/fpn+/- mice compared to the control 
mice the total amount of GPx-4 was reduced by 20%. Thus, combination of leptin signaling 
and impaired iron homeostasis (iron overload) decreased the amount of GPx-4 protein in the 
glomeruli of 32-42 weeks old male mice. 
Next the area of the synaptopodin stained glomeruli was compared between the respective 
groups of 32-42 weeks old male mice. There was no change in the total size of the glomeruli 
in 32-43 weeks old male fpn+/- mice compared to their homozygous littermates (Figure 43). 
The size of the glomeruli in db/db mice compared to their heterozygous littermates was not 
changed as well.  
 
Figure 43: Impact of leptin signaling and impaired iron homeostasis on the size of the 
glomeruli of 32-42 weeks old male mice. The area of the glomeruli was determined in cryosections 
of kidneys from 32-42 weeks old male db/db mice, their heterozygous littermates, fpn+/- mice and 
db/db/fpn+/- mice. Means ± SD of n=7-8 per group are shown. 
Moreover, in db/db/fpn+/- mice the size of the glomeruli was non-significantly increased by 25 
% compared to the control mice. Summarized, an impaired leptin signaling slightly changed 
the glomerular area of 32-42 weeks old male mice. This effect seemed to be more enhanced 
in the db/db/fpn+/- mice. 
In the last step the amount of GPx-4 protein per area in the synaptopodin stained glomeruli  
was determined and compared between the respective groups of mice at the age of 32-42 
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weeks. The amount of GPx-4 protein per area was not altered 32-42 weeks old fpn+/- mice 
compared to their homozygous littermates (Figure 44). In contrast, the amount of GPx-4 
protein per area was non-significantly reduced by 32 % in db/db mice compared to their 
heterozygous littermates. Moreover, the amount of GPx-4 protein per area was significantly 
reduced by 37 % in db/db/fpn+/- mice compared to the respective control mice. 
Summarized, an impaired leptin signaling changed the amount of GPx-4 protein 
abundance/area in the glomeruli of 32-42 weeks old male mice. This effect seemed to be 
more enhanced in the db/db/fpn+/- mice. Thus, during the progression of the disease the 
combination of impaired leptin signaling and iron overload decreased the amount of GPx-4 in 
32-42 weeks old male mice. 
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Figure 44: Impact of leptin signaling and impaired iron homeostasis on GPx-4 protein 
abundance in the glomeruli of 32-42 weeks old male mice. Positive GPx-4 staining was quantified 
as mean intensities (as described in MM (section 5.1.9, page 52) from cryosections of kidneys from 
32-42 weeks old male db/db mice, their heterozygous littermates, fpn+/- mice and db/db/fpn+/- mice. 
The values obtained from the GPx-4 staining were normalized with the area of the synaptopodin 
stained glomerulus. Means shown as GPx-4 protein abundance/area ± SD of n=7-8 per group are 
shown. *p<0.05 as indicated 
 
6.5.4 GPx-4 protein abundance is not altered in the glomeruli of 23 weeks old 
ob/ob mice 
 
In order to test whether the reduction in the amount of GPx-4 protein abundance/area in the 
glomeruli of 32-42 weeks old male db/db/fpn+/- mice is mediated through the binding of the 
hormone leptin to the short splice variants of the leptin receptor ObRa and ObRc, ob/ob mice 
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have been used as a control group. Thus, GPx-4 was stained in cryosections of kidneys from 
23 weeks old ob/ob mice as well as from kidneys of their heterozygous littermates.  
The amount of GPx-4 protein in the glomeruli was not altered in homozygous ob/ob mice 
compared to their heterozygous littermates (Figure 45). Thus, in the absence of leptin, hence 
leptin signaling, the amount of GPx-4 protein in the glomeruli of 23 weeks old male ob/ob 
mice is not altered. 
 
Figure 45: Impact of leptin deficiency on mean GPx-4 protein abundance in the glomeruli of 23 
weeks old male mice. Positive GPx-4 staining was quantified as mean intensities (as described in 
MM (section 5.1.9, page 52) from cryosections of kidneys from 23 weeks old male ob/ob mice as well 
as from their heterozygous littermates. Means ± SD of n=6-7 per group are shown. 
  
 
Figure 46: Impact of leptin deficiency on the size of the glomeruli of 23 weeks old male mice. 
The area of the synaptopodin stained glomeruli was determined in cryosections of kidneys from 23 
weeks old male ob/ob mice, as well as from their heterozygous littermates. Means ± SD of n=6-7 per 
group are shown. *p<0.05 as indicated 
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In the next step the area of the synaptopodin stained glomeruli was compared between the 
two groups of mice. In homozygous ob/ob mice the size of the glomeruli was significantly 
increased by 30 % when compared to the heterozygous control mice (Figure 46). The 
disease has already progressed, thus the size of the glomeruli of 23 weeks old male ob/ob 
mice is significantly increased. 
In the last step the amount of GPx-4 protein per area in the glomeruli was determined and 
compared between the two groups of mice.  
 
Figure 47: Impact of leptin deficiency on the size of the glomeruli of 23 weeks old male mice. 
Positive GPx-4 staining was quantified as mean intensities (as described in MM (section 5.1.9, page 
52) from cryosections of kidneys from 23 weeks old male ob/ob mice, as well as from their 
heterozygous littermates. The values obtained from the GPx-4 staining were normalized with the area 
of the glomerulus. Means shown as GPx-4 protein abundance/area ± SD of n=6-7 per group are 
shown. 
 
The amount of GPx-4 protein per area was not significantly altered in homozygous 23 weeks 
old ob/ob mice compared to their heterozygous littermates (Figure 47). Thus, in the absence 
of leptin the amount of GPx-4 protein abundance/area was not changed in the glomeruli of 
23 weeks old male mice.  
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7. Discussion 
7.1 The source of reactive oxygen species in T2D 
 
All cells produce ROS on a continuous basis and at a steady-state level under normal 
physiological conditions (Ray, Huang et al. 2012, Haas and Staels 2016). Under conditions 
of excessive glucose production (Tang, Luo et al. 2014), it is still unclear whether ROS cause 
or merely correlate with diabetic complications (Kashihara, Haruna et al. 2010). ROS play a 
crucial role in signal transduction processes (Fattman, Schaefer et al. 2003) such as in some 
ligand-receptor interactions (Ray, Huang et al. 2012). Prominent examples for such ligand-
receptor interactions are the cytokines tumor necrosis factor α or interleukin-1β (Haas and 
Staels 2016). In addition, ROS can activate kinases and phosphatases and therefore change 
the degree of phosphorylation of other proteins (Ray, Huang et al. 2012, Haas and Staels 
2016). Moreover, ROS can interfere with gene expression via modulation of transcription 
factors (Brieger, Schiavone et al. 2012). 
There is evidence for increased ROS levels in kidneys in experimental diabetes (Poulianiti, 
Kaltsatou et al. 2016, Cooper, El-Osta et al. 2018). There is also evidence for increased ROS 
in clinical diabetes (Tavafi 2013, Poulianiti, Kaltsatou et al. 2016, Cooper, El-Osta et al. 
2018). Moreover, increased oxidative stress could be verified in patients with diabetes by 
measuring thiobarbituric acid reactive substances (TBARS) like malondialdehyde (MDA) and 
4-hydroxynonenal (4-HNE) (Martín-Gallán, Carrascosa et al. 2003). MDA does not 
exclusively originate from breakdown of polyunsaturated fatty acids (PUFAS) (Browne and 
Armstrong 2000). Thus, it is only a marker for oxidative stress but does not give any 
information from where and how ROS emerge. Some authors claim NADPH oxidases (NOX) 
have an important role in the progression of diabetes as they contribute to ROS formation 
(Gill and Wilcox 2006). The isoform NOX-4, which is predominately expressed in the kidney 
cortex and produces hydrogen peroxide only, is upregulated in in vitro experiments using 
hyperglycemic conditions  (Thallas-Bonke, Jandeleit-Dahm et al. 2015). 
These studies provide experimental as well as clinical evidence that diabetes can be 
characterized by increased oxidative stress, but this phenotype is not necessary associated 
with alterations in mitochondrial function (Newsholme, Haber et al. 2007, Cooper, El-Osta et 
al. 2018). In summary, almost all published studies have shown a uniform “over-production” 
of ROS in the tissues of animals and patients with diabetes (Zhang, Darshi et al. 2018). 
Moreover, ebselen, a pharmacologic analog to GPx-1, can improve proteinuria and limits the 
overall degree of diabetic nephropathy in ApoE/GPx-1 knockout mice (Chew, Yuen et al. 
2010).  
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In hyperglycemic conditions ATP production is switched from oxidative phosphorylation to 
glycolysis. Superoxide dismutase (SOD) levels are not altered in people suffering from T2D 
(Zhang, Darshi et al. 2018). There is also no evidence that superoxide is increased in 
patients with T2D (Zhang, Darshi et al. 2018). Therefore, we do not assume that alternative 
pathways are activated. Thus, we think hyperglycemia itself is not the driving cause for 
devolving diabetic nephropathy. Moreover, this shows us that there is no increase in ROS 
production. In contrast, H2O2 levels are increased but not at mitochondrial sides (Zhang, 
Darshi et al. 2018). We conclude there seems to be a problem with ROS detoxification.  
 
7.2. Detection of leptin receptor splice variants  
 
One. overarching goal of this thesis was to show on a qualitative and on a quantitative level 
that the CI-muMECs as well as the gECs contain the transcripts of the leptin receptor splice 
variants Ob-Rb, Ob-Ra and Ob-Rc. As mentioned in chapter 3.3 the long leptin receptor 
splicet variant Ob-Rb is highly abundant in the hypothalamus and known to be responsible 
for leptin signaling causing a decrease of food intake and an increase of energy expenditure. 
Until today it is not known whether leptin resistance is caused by the inability of leptin to bind 
to its receptor Ob-Rb or an impaired transport via the blood-brain barrier. In peripheral 
tissues, the short splice variants Ob-Ra and Ob-Rc are highly abundant (Goto, Kaneko et al. 
2016). We could confirm that in CI-muMECs the amount of Ob-Ra transcript is 3.3-fold 
higher compared to theOb-Rb transcript, and in gECs the amount of Ob-Ra is 1.4-fold higher 
compared to Ob-Rb. Even though it was long time believed that only Ob-Rb is able to 
transmit a signal downstream, more and more publications claim that also the short leptin 
receptor splice variants are able to transmit a signal downstream (Goto, Kaneko et al. 2016). 
Thus, high leptin concentrations as detected in patients with T2D should lead to increased 
downstream signaling in these cells. It needs to be determined which leptin receptor splice 
variant is responsible for leptin signaling in other organs as the brain, such as e.g. the 
kidney.  
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7.3. Cell culture 
7.3.1 TGF-β1 mRNA expression and active TGF-β1 in the supernatant of leptin-
stimulated endothelial cells 
 
Leptin levels are five times higher in obese people (40 ng/mL leptin) compared to healthy 
individuals (8 ng/mL leptin) (Li, Shen et al. 2013). We could show, that endothelial cells 
contain transcripts of the leptin receptor. Moreover, it was published that gECs release TGF-
β1 in co-culture with in the presence of epithelial cells (proximal tubular epithelial cells) 
(Zhao, Zhao et al. 2014). Furthermore, leptin induces hepatic fibrosis most likely through the 
action of TGF-β1 (Honda, Ikejima et al. 2002). In addition, it was shown that gECs respond to 
leptin with an increased secretion of TGF-β1 (Wolf, Chen et al. 2002). Thus, we investigated 
whether CI-muMECS and gECs respond to leptin binding.  
CI-muMECs did not respond to leptin stimulation on the transcriptional level. We could not 
detect an increase of TGF-β1 transcripts in leptin-stimulated CI-muMECs compared to non-
stimulated controls. Thus, we assumed a potential role in TGF-β1 processing in response to 
leptin-stimulation. Indeed, we measured a significant 1.6-fold increase of activated TGF-β1 in 
the cell culture medium of leptin-stimulated CI-muMECs (100 ng/mL) compared to the non-
stimulated controls. We could confirm this result analyzing the cell culture medium of leptin-
stimulated gECs. In this case, we measured a significant 1.24-fold increase of activated 
TGF-β1 in the cell culture medium of leptin-stimulated gECs (100 ng/mL) compared to the 
non-stimulated controls. The observed different fold-changes between CI-muMECs (1.24) 
and gECs (1.6) can be explained by different background levels of naïve TGF-β1 in the FCS 
of the respective medium. To avoid such differences naïve TGF-β1 could be depleted using 
TGF-β1 antibody coupled magnetic beads before incubating the endothelial cells with the 
respective medium. It is not known, which leptin receptor splicing variant is responsible for 
the observed signaling. We can only predict at this point that one of the small splice variants 
is involved resulting in JAK/STAT signaling, even though it is not confirmed that the short 
splice variants are able to signal via this signaling pathway (Han, Isono et al. 2001). 
Consequently, phosphorylated STAT 1,3 heterodimers might translocate to the nucleus 
activating gene transcription. Potential candidate genes might be metalloproteases, inter alia 
metalloprotease 9 (MMP9) (Travis and Sheppard 2014). Furthermore, leptin has the potential 
to induce ROS in endothelial cells (Adya, Tan et al. 2015). ROS on the other hand can 
cleave both, TGF-β1 and MMP9 resulting in active TGF-β1 and active MMP9. Besides ROS 
or changes in the pH, MMP9 is one of the factors that can cleave TGF-β1 resulting in active 
TGF-β1 as well (Liu and Desai 2015). People suffering from T2D have high circulating leptin 
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levels. Thus, we assume leptin increases the release/activation of TGF-β1 from the matrix of 
glomerular endothelial cells in these people. Moreover, TGF-β1 reduces podocyte adhesion 
to the glomerular basal membrane via downregulation of α3β1 integrin (Wolf, Chen et al. 
2002, Wolf 2004, Vallon and Komers 2011). It might induce epithelial to mesenchymal 
transition of podocytes by attenuating epithelial markers and by acquisition of mesenchymal 
markers resulting in podocyte depletion (Miyazono 2009). Moreover, TGF-β1 impairs the 
architecture of slit-diaphragm (Vallon and Komers 2011), alters the perm-selectivity of 
podocytes and increases podocyte apoptosis (Wolf, Chen et al. 2002, Vallon and Komers 
2011). 
 
7.3.2. GPx-1 and GPx-4 protein abundance in leptin-stimulated or TGF-β1-
stimulated E11 podocytes  
 
A podocyte loss was observed in kidney biopsies from people with T2D suffering from 
diabetic nephropathy as well as in mouse models mimicking the human disease (Susztak, 
Raff et al. 2006). It is not known whether podocyte loss occurs early at the stage of 
microalbuminuria or late at the stage of ESRD. It is also unknown whether podocyte foot 
process enfacement causing podocyte detachment and hence podocyte loss into the urine 
(Vogelmann, Nelson et al. 2003) is responsible for this loss of podocytes or whether 
podocytes simply die from a regulated or a non-regulated form of cell death. Some authors 
claim podocytes detach from the GBM during the progression of the disease (Petermann, 
Krofft et al. 2003). The only available data was generated in an experimental membranous 
nephropathy set-up, not reflecting the pathophysiological conditions observed in diabetic 
nephropathy in humans or mouse models mimicking the human disease. In line with the 
genome wide association studies (Zhang, Darshi et al. 2018) we assume that podocyte loss 
occurs early at the stage of microalbuminuria (Schiffer, Susztak et al. 2005) and is caused by 
a regulated cell death termed ferroptosis. Therefore, we came up with the hypothesis that an 
inadequate detoxification of hydrogen peroxide as well as lipid hydroperoxides causes 
irreversible damage to the podocytes, which ends with their ferroptotic cell death and 
therefore with a loss of these cells. For this reason, the amount of GPx-1 and especially 
GPx-4 protein was analyzed in E11 podocytes after exposure to either leptin or TGF-β1. 
Leptin itself had no impact on GPx-1 or GPx-4 protein abundance. Moreover, the amount of 
GPx-1 protein was not altered after TGF-β1 stimulation. Contrary to our findings, it was 
published that TGF-β1 can induce GPx-1 in colon cancer cells (Huang, Fang et al. 2012). 
Furthermore, in TGF-β1-stimulated E11 podocytes the amount of GPx-4 protein was 
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significantly reduced in a dose-dependent as well as in a time-dependent manner. These 
findings are in line with publications showing that TGF-β1 can suppress the antioxidant 
defense by inducing redox imbalances (Liu and Desai 2015). The kinetics of primary 
podocytes seemed to be different as short-time (24-48 hours) exposure to TGF-β1 as the 
GPx-4 protein content was not changed. The response of primary podocytes might be 
delayed a few days, compared to the E11 podocytes, because other naturally occurring 
signaling pathways might interfere with the observed TGF-β1 signaling. Thus, the time of 
future experiments should be prolonged a few days to receive a similar downregulation of the 
amount of GPx-4 protein obtained from TGF-β1-stimulated E11 podocytes.  
 
7.3.3. GPx-4 protein abundance in E11 podocytes exposed to TGF-β1 and/or 
iron overload 
 
Ferroptosis is characterized by a reduction of GPx-4 activity and/or protein abundance, an 
accumulation of lipid peroxides and excess iron. The source of iron remains unknown. Some 
authors described ferroptosis as an autophagic cell death of ferritin (Gao, Monian et al. 
2016). They concluded that this is the reason for a dramatic increase of the labile iron pool. 
More iron causes more Fenton reaction (Lee, Choi et al. 2015). Thus, more lipid peroxides 
are generated. In order to test this hypothesis iron donors were added to the pre-existing set-
up. The iron donors apotransferrin and holotransferrin seemed to have no additional effect on 
the downregulation of GPx-4 protein abundance in TGF-β1-stimulated E11 podocytes. The 
iron donor FeNTA (Lee, Choi et al. 2015) added to TGF-β1-stimulated E11 podocytes did 
also not change the amount of GPx-4 protein in E11 podocytes. Thus, hyperglycemic 
conditions might be necessary to initiate the self-reinforcing feedback loop.  
 
7.3.4. GPx-4 protein abundance in E11 podocytes exposed to TGF-β1 and/or 
iron overload in high-glucose medium 
 
Even though we believe that hyperglycemia is not the primary course for developing diabetic 
nephropathy (Falkevall, Mehlem et al. 2017), we have to consider that podocytes are more 
susceptible to high glucose concentrations, as their regulation of glucose uptake is different 
compared to other cells types and can be triggered by the glucose concentration or by 
mechanical stress (Lewko, Bryl et al. 2005). Thus, we hypothesized that in addition to the 
exposure to TGF-β1 and an iron donor, hyperglycemic conditions (30 mM glucose) are 
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necessary to initiate the feedback loop. Therefore, E11 podocytes were exposed to TGF-β1 
and holotransferrin under hyperglycemic conditions. Remarkably, we could not detect a 
further downregulation of GPx-4 protein, compared to the E11 podocytes cultured with 
normal glucose (5 mM glucose). Moreover, we assumed that iron has an indirect influence 
on GPx-4, not by causing a stronger reduction of the GPx-4 protein amount but rather by 
inhibiting the GPx-4 activity through this increased glutathione consumption. Thus, GPx-4-
specific activity was measured in E11 podocytes treated with TGF-β1 and holotransferrin 
under hyperglycemic conditions for 3 days.  Indeed, we could show that GPx-4 activity is 
reduced by 29% in these cells compared to the control group. This effect was similar to the 
observed reduction on the protein level. We therefore conclude that the overall reduction of 
GPx-4 activity is due to the reduction of GPx-4 protein. In the cell culture system GPx can be 
blocked with erastin. Erastin blocks system Xc, which is an antiporter transporting glutamate 
outside the cell and cystine inside the cell (Yang, SriRamaratnam et al. 2014, Conrad and 
Friedmann Angeli 2015, Shah, Shchepinov et al. 2018). Cystine is then converted to cysteine 
and used for synthesizing glutathione. Besides its ability to unspecifically block the activity of 
all GPx, GPx-4 can be specifically and directly inhibited by the Ras small molecule like 
inhibitor 3 (RSL-3) (Yang, SriRamaratnam et al. 2014, Shah, Shchepinov et al. 2018). We 
could show that RSL-3 is a potent GPx-4 inhibitor which inhibits the activity of GPx-4 by 100 
% in vitro mimicking the in vivo situation of patients suffering from T2D. Clinical studies have 
shown that patients suffering from T2D exhibit significantly less GPx-4 enzyme and a 
subsequent accumulation of HNE-adducts in their hearts compared to healthy individuals 
(Katunga, Gudimella et al. 2015). 
 
7.3.5. GPx-4 expression in podocytes co-cultured with endothelial cells 
 
Similar to the situation in the kidney, endothelial cells and podocytes were co-cultivated as 
described in chapter 6.3.3. We could confirm that GPx-4 protein abundance was significantly 
reduced in leptin-stimulated E11 podocytes co-cultured with CI-muMECs. The amount of 
GPx-4 protein was not changed in leptin-stimulated gECs co-cultured with E11 podocytes 
and co-cultured with primary podocytes. As already discussed in chapter 7.2.4. it is likely that 
our cell-culture system did not cover all the characteristics which emerge in the 
pathophysiological state of diabetic nephropathy in humans and in the respective mouse 
model. It is likely that the simultaneous action of a reduction of GPx-4 protein/activity, excess 
iron and hyperglycemic conditions is needed. The last point was missing in our co-culture 
model. Oxidative stress from glucose metabolism (Latunde-Dada 2017) can trigger the 
feedback loop. As cells constantly metabolize glucose, the glucose in the medium drops 
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constantly as well. Thus, these cells were only exposed to high glucose concentrations for a 
short period of time. Therefore, it is likely that hyperglycemia needed to activate and drive the 
feedback loop was not contributing to the programmed cell death ferroptosis. Glucose 
consumption experiments are necessary to quantify the amount of consumed glucose per 
day. In a next step, the amount of metabolized glucose can be added to the co-culture 
system on a daily basis to ensure constant hyperglycemic conditions. In addition, it might be 
necessary to prolong the time the cells are co-cultured.  
 
7.4. Leptin receptor-deficient mice lacking the long leptin receptor splicing 
variant (Ob-Rb) 
 
Even though mouse models of diabetes reflect most of the features of human diabetes, they 
do not cover all characteristics. During the development and the progression of diabetic 
nephropathy in mice characteristics such as glomerular hyperfiltration, increased albuminuria 
and specific histopathologic changes as GBM thickening and expansion of the mesangium 
are similar to human diabetic nephropathy, whereas diabetic nephropathy in mice never 
proceeds to ESRD (Breyer, Bottinger et al. 2005). As already discussed in chapter 6.4 db/db 
mice carry a point mutation in the long leptin receptor splice variant Ob-Rb causing a 
premature termination of the translation of this splice variant. Moreover, the premature 
termination of leptin receptor splice variant Ob-Rb leads to the translation of the short splice 
variant Ob-Ra.  
 
Figure 47: Blood glucose in B6.BKS(D)-Lepr
db
/J mice. Graph was supplied from Jackson 
Laboratory 
According to our hypothesis, leptin resistance in the brain caused by an impaired leptin 
transport via the blood-brain-barrier does not imply that leptin signaling in the periphery such 
as the kidney is impaired. It is likely that leptin binds to the short splice variants causing a 
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downstream signaling leading to an increased release/activation of TGF-β1. Furthermore, we 
think that this effect is more pronounced in db/db mice as truncated transcript Ob-Rb as well 
as transcript Ob-Ra are both translated into Ob-Ra. The point mutation was first introduced in 
the BKS mouse strain and then several times backcrossed to the B6 mouse strain. The 
original mouse strain develops a severe diabetic phenotype with more severe kidney 
damage. The reason might be the glucose level, as male B6.BKS(D)-Leprdb/J mice are only 
transiently hyperglycemic. Hyperglycemia increases until 8 weeks of age and drops back to 
normal level at 12 weeks of age (Figure 47). For this reason, we assume that ferroptosis inter 
alia podocyte damage is less severe compared to the B6 mouse strain.  
 
7.5. Ex vivo experiments 
7.5.1. Extracelluar matrix expansion in the glomeruli of 32-42 weeks old fpn+/- 
and db/db mice 
 
Characteristic histopathologic changes of diabetic nephropathy as the expansion of the 
mesangium were previously described in db/db mice (Sharma, McCue et al. 2003). Thus, we 
quantified the amount of extracellular matrix in 24 and 32-42 weeks old db/db mice. We 
could not detect a significant accumulation of extracellular matrix in 24 weeks old db/db mice, 
in fpn+/- mice or in db/db/fpn+/- mice compared to the wildtype littermates. In 32-42 weeks old 
db/db mice, we could detect a significant accumulation of extracellular matrix compared to 
the wildtype littermates. This effect was more pronounced in the db/db/fpn+/- mice. Thus, both 
iron as well as leptin signaling have a detrimental effect on the kidneys during the 
progression of the disease, as both contribute to the expansion of the mesangium, a 
histologic phenotype of diabetic nephropathy (Brosius, Alpers et al. 2009). 
 
7.5.2. Iron accumulation in the glomeruli of 32-42 weeks old fpn+/- mice 
 
Previous published data revealed that T2D is associated with a systemic iron overload (Lee, 
Choi et al. 2015, Altamura, Kopf et al. 2017) that leads to more ROS formation (Lee, Choi et 
al. 2015, Handa, Morgan-Stevenson et al. 2016). For the first time it was shown that 
epithelial cells in the liver of db/db mice have a significant higher iron content, compared to 
their wild-type littermates (Altamura, Kopf et al. 2017). Thus, we investigated whether this is 
also true for epithelial cells in the kidney. Unfortunately, we could not discriminate between 
iron-positive podocytes and iron-positive endothelial or mesangial cells and therefore we 
quantified the amount of iron in the whole glomeruli of the respective mice. There was no iron 
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accumulation in 24 weeks old fpn+/- mice as well as in db/db/fpn+/- mice detectable. In 32-42 
weeks old fpn+/- mice the amount of iron was significantly increased compared to their 
wildtype littermates. This effect was more pronounced in db/db/fpn+/- mice. It was reported 
that iron has the ability to form complexes with low molecular weight molecules such as 
glutathione (Fanzani and Poli 2017). This can be crucial, as glutathione is depleted in many 
diseases (Bertrand 2017). In case of a glutathione depletion below a certain threshold the 
labile iron pool could be suddenly increased. 
 
7.5.3. GPx-4 protein reduction in the glomeruli of 32-42 weeks old db/db mice 
 
As already discussed there is evidence for increased ROS in kidneys in experimental 
diabetes, but the data of the activity or the protein abundance of the antioxidative enzymes 
SOD and catalase are contradictory (Poulianiti, Kaltsatou et al. 2016). Some studies claim 
the activity or the protein abundance of SOD or catalase is decreased (Fattman, Schaefer et 
al. 2003), some claim the activity or the protein abundance of SOD or catalase is increased 
(Thallas-Bonke, Jandeleit-Dahm et al. 2015) in the respective mouse or rat model mimicking 
diabetes. Until today, there is also no convincing data about the GPx-4 protein abundance or 
the GPx-4 activity in the glomeruli of mice suffering from diabetes available. As already 
published by Tanja Wiedenmann (Wiedenmann, Dietrich et al. 2018) GPx-1 and GPx-4 
protein abundance are significantly reduced in the glomeruli of people with T1D as well as in 
the glomeruli of people with T2D. We investigated, whether GPx-4 protein abundance is 
reduced to the same degree in our mouse model for T2D. If so, the db/db mice in 
combination with the systemic iron overload could be used to identify the underlying 
mechanism responsible for the progression of the disease. 
In 24 weeks old db/db mice the amount of GPx-4 protein was significantly increased 
compared to their wildtype littermates (chapter 6.5.3). In all other groups the amount of GPx-
4 protein abundance was not altered. Moreover, the area of the synaptopodin stained 
glomeruli was significantly increased in the db/db mice as well as in the db/db/fpn+/- mice. To 
get a more exact comparable value, the values obtained from the GPx-4 staining were 
normalized with the area of synaptopodin stained glomeruli. Neither leptin signaling, nor 
excess iron changed the amount of GPx-4 protein in 24 weeks old mice compared to their 
wild-type littermates. The action of both excess iron and leptin signalling significantly reduced 
the amount of GPx-4 protein. To conclude, the increase in the amount of GPx-4 protein in 
db/db mice was mainly due to the increased size of the glomeruli, as quantified normalized 
data showed no difference. The amount of GPx-4 protein abundance was even further 
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decreased after normalization which substantiates that this effect is not due to the increased 
size of the glomeruli. 
In 32-42 weeks old db/db mice as well as in db/db/fpn+/- mice the amount of GPx-4 protein 
was slightly decreased compared to their wild-type littermates. Furthermore, the area of the 
synaptopodin stained glomeruli was slightly increased in the db/db mice as well as in the 
db/db/fpn+/- mice. Excess iron did not change the amount of GPx-4 protein in this aged group 
of mice comparing normalized GPx-4 values, whereas the amount of GPx-4 protein was 
slightly decreased in the db/db mice. In contrast, the amount of GPx-4 protein abundance 
was significantly reduced in the db/db/fpn+/- mice. To conclude, the action of both excess iron 
and leptin signalling is needed to reduce the amount of GPx-4 protein abundance. One can 
speculate that this effect is more pronounced in the BKS db/db mouse strain, as 
hyperglycemia is only transient in B6 db/db mice. As already discussed hyperglycemia is a 
potential candidate that triggers the feedback loop described above.   
GPx-1 knockout mice have no severe phenotype, whereas GPx-4 knockout mice do not 
survive more than two weeks. This shows us that other redox enzymes such as other GPx 
isoforms or catalases can compensate for the loss of GPx-1 but not the loss of GPx-4 (Yang, 
SriRamaratnam et al. 2014). In the mammalian system there seems to be no effective 
redundant mechanism available (Brigelius-Flohe and Maiorino 2013). 
In order to prove that leptin signalling via the short leptin receptor splice variants Ob-Ra or 
Ob-Rc, rather than the absence of leptin signalling via the long leptin receptor splice variant 
Ob-Rb is responsible for the downregulation of GPx-4 protein abundance in the db/db mice, 
we used the leptin deficient ob/ob mice. Thus, we quantified the amount of GPx-4 protein in 
the synaptopodin positive stained glomeruli of the respective mice. The amount of GPx-4 
protein was not changed compared to their wild-type littermates. In contrast, the area of the 
synaptopodin stained glomeruli was significantly increased in ob/ob mice compared to their 
wildtype littermates. The amount of GPx-4 protein was not changed in ob/ob mice compared 
to their wildtype littermates using normalized GPx-4 values. To conclude, leptin-deficiency 
does not change the amount of GPx-4 protein abundance in the glomeruli of these mice.  
As the difference between db/db mice and ob/ob mice emerges from the impaired leptin 
signalling, we conclude that this is detrimental for the progression of diabetic kidney disease. 
We could show that leptin signalling via the short splice variants of the leptin receptor leads 
to a downregulation of GPx-4 protein abundance in the glomeruli. This substantiate the 
hypothesis that there is no problem with ROS production but rather with ROS detoxification 
(Chew, Yuen et al. 2010).  
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7.6. Outlook 
7.6.1. In vivo activation of the feedback loop 
 
Glutathione depletion is associated with different neurodegenerative diseases such as 
Alzheimer’s disease, Parkinson’s disease and Huntington’s disease (Bertrand 2017). A 
decrease in GSH levels was also observed in patients with T1D (Martín-Gallán, Carrascosa 
et al. 2003). The reason, why GSH levels are decreased in these patients is not known. One 
reason could be that GSH depletion inhibits the apoptotic program (Cao and Dixon 2016). 
Furthermore, it was suggested that increased TGF-β1 is responsible for GSH depletion in 
fibrotic diseases such as cystic fibrosis, chronic obstructive pulmonary diseases, acute 
respiratory distress syndrome and chronic liver diseases (Liu and Desai 2015). Moreover, it 
was shown that despite the direct impact of TGF-β1 signalling, an additional dysregulation of 
glutathione synthesis might be the reason for a low glutathione pool (Cao and Dixon 2016). 
Moreover, lysosomes contain a quite large labile iron pool, as they are involved in iron 
import, iron storage and iron recycling (Doll and Conrad 2017). Followed by a significant 
reduction of the amount of GPx-4 protein, an accumulation of lipid peroxides might have an 
impact on the permeability of the lysosomal membranes releasing iron into the cytoplasm. 
This might result in a significant depletion of the glutathione pool, as Fenton reaction occurs 
more often. Preliminary results generated in cooperation with Prof. Bernhard Spengler 
(Justus-Liebig-University Gießen, Institute of Anorganic and Analytic Chemistry) showed that 
the PE lysoform 18:0 accumulates in TGF-β1 and iron treated E11 podocytes cultured in 
high-glucose medium or in RSL-3 treated E11 podocytes similar to the experiments 
performed in chapter 3.6.2.4. The amount of the PE lysoform was defined by the ratio of lyso 
PE (18:00) to PE (38:4) and lyso PE (18:00) to PE (40:6). These results are in line with 
published data showing an accumulation of these lysophospholipids after peroxidation of 
PUFAs (Else and Kraffe 2015). Further experiments are needed to reliably quantify these 
lysoforms. Surprisingly, only one research group connected the accumulation of these 
lysoforms to a loss of GPx-4 protein (Toppo, Flohe et al. 2009) and no research group 
connected these results to ferroptotic cell death. In a next step, the amount of PC, PE and 
cardiolipin lysoforms will be analyzed in tissue of db/db mice, fpn+/- mice and in tissue of 
db/db/fpn+/- mice. According to our hypothesis these lysoforms should accumulate in our 
mouse models mimicking diabetic nephropathy of T2D. 
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7.6.2 Quantification of TGF-β1 in mouse models of T2D 
 
TGF-β plays a key function in diabetic nephropathy (Lee, Guh et al. 2004). Endothelial cells 
respond to leptin via an increase/release of activated TGF-β1 (Chapter 6.3.1 and 6.3.3). 
Moreover, podocytes respond to TGF-β1 with a subsequent downregulation of the amount of 
GPx-4 protein abundance (Chapter 6.3.2). Next, our in vitro data needs to be confirmed ex 
vivo. It was already published that db/db mice contain more glomerular TGF-β1 (Sharma, 
McCue et al. 2003). As already discussed the amount of active TGF-β1 should be increased 
in the db/db mice and even further increased db/db/fpn+/- mice. TGF-β1 not only has a direct 
effect on the amount of GPx-4 protein abundance. It also has a direct effect on the 
composition of the GBM, as it stimulates the alpha3 chain of type IV collagen, whereas it 
inhibits the level of the alpha5 chain. The GBM consists in large parts of type IV collagen 
(Chen, Kasama et al. 2004). In contrast, it was published that TGF-β1 activates hepcidin 
mRNA expression in hepatocytes (Chen, Feng et al. 2016). This is contradictory to our 
hypothesis as hepcidin levels where found to be significantly reduced in patients suffering 
from diabetes (Altamura, Kopf et al. 2017). Moreover, it was published that TGF-β1 is a key 
factor regulating fibrosis. In addition, it is debated whether TGF-β1 is able to induce epithelial 
to mesenchymal transition (EMT) (Loeffler and Wolf 2015) or endothelial to mesenchymal 
transition (endoMT) in the kidney (Zeisberg, Potenta et al. 2008).  
The mechanism by which TGF-β1 reduces GPx-4 protein abundance is not known. TGF-β1 
binding to the podocytes might lead to Smad 2/3 phosphorylation (Miyazono 2009, Liu and 
Desai 2015). This could then activate the proteasome resulting in an increased degradation 
of the protein GPx-4. Inactivation or a reduction of GPx-4 protein seems to be enough to 
induce ferroptosis (Gao, Monian et al. 2016).  
 
7.6.3 Obesity and overfeeding might drive the pathophysiological changes in 
the kidney 
 
As already discussed in chapter 7.4 leptin signaling in peripheral tissue might be the reason 
for the paracrine TGF-β1 signaling causing the reduction of GPx-4 protein abundance in the 
podocytes resulting in the programmed cell death termed ferroptosis. Besides leptin signaling 
in peripheral tissue such as the kidney, excess free iron is needed to drive the 
pathophysiological changes in the kidney contributing to an early podocyte loss. Increased 
signaling via mammalian target of rapamycin (mTOR) caused by excess nutrients is 
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suspected to be the reason for increased phosphorylation of Akt resulting in the 
downregulation of hepcidin expression in the liver. Thus, constantly active ferroportin 
implements a systemic iron overload leading to an iron accumulation in the podocytes. One 
of the key characteristics of an obese phenotype during the progression of the metabolic 
syndrome is the development of insulin resistance. Interestingly, insulin binding to the insulin 
receptor activates PDK1, which phosphorylates Akt (Dupont and Scaramuzzi 2016). 
Moreover, mTOR plays a key role in insulin signaling  (Hale and Coward 2013). Furthermore, 
hyperglycemic conditions are needed in order to activate the feedback loop. Podocytes are 
able to sense and respond to increased insulin levels as they contain glucose transporter 1 
and 4, which contribute to insulin-induced glucose uptake (Coward, Welsh et al. 2005). In 
addition, overall glucose concentration and mechanical stress can modulate glucose 
transport into the podocytes sensitizing them to hyperglycemic conditions (Lewko, Bryl et al. 
2005).   
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